Determine 10-K 29 Jun 15 2015 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2015	Jun. 12, 2015	Sep. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	SELECTICA INC
Document Type	10-K
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		9,214,083
Entity Public Float			$ 36,468,653
Amendment Flag	false
Entity Central Index Key	1,090,908
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2015	Mar. 31, 2014
Current assets
Cash and cash equivalents	$ 13,178	$ 16,907
Accounts receivable, net of allowance for doubtful accounts of $205 and $247 as of March 31, 2015 and March 31, 2014, respectively	5,203	3,006
Restricted cash	34
Prepaid expenses and other current assets	1,647	689
Total current assets	20,062	20,602
Property and equipment, net	290	312
Capitalized software development costs, net	2,258	856
Goodwill	7,702
Other intangibles, net	6,453
Other assets	521	30
Total assets	37,286	21,800
Current liabilities
Credit facility	7,447	6,949
Accounts payable	1,535	1,371
Accrued payroll and related liabilities	910	648
Other accrued liabilities	1,877	345
Deferred revenue	8,410	5,131
Total current liabilities	20,179	14,444
Long-term deferred revenue	22	618
Convertible note, net of debt discount	2,900
Other long-term liabilities	167
Total liabilities	$ 23,268	$ 15,062
Commitments and contingencies (Notes 9 and 10):
Stockholders' Equity:
Common stock, $0.0001 par value: Authorized: 15,000 shares at March 31, 2015 and 2014; Issued: 8,019 and 4,790 shares at March 31, 2015 and 2014, respectively; Outstanding: 7,923 and 4,694 shares at March 31, 2015 and 2014, respectively	$ 5	$ 4
Additional paid-in capital	297,866	278,083
Treasury stock at cost - 96 shares at March 31, 2015 and 2014	(472)	(472)
Accumulated deficit	(288,276)	(274,530)
Total stockholders' equity	9,123	3,085
Total liabilities, redeemable convertible preferred stock and stockholders' equity	37,286	21,800
Series F and Series D Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock:
Series F and Series D redeemable convertible preferred stock, $0.0001 par value, designated, issued and outstanding shares: 118,829 shares at March 31, 2015 and 680,047 at March 31, 2014, respectively	$ 4,895	$ 3,653

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2015	Mar. 31, 2014
Accounts receivable, allowance for doubtful accounts (in Dollars)	$ 205	$ 247
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock,Authorized Shares	15,000,000	15,000,000
Common stock, issued	8,019,000	4,790,000
Common stock, outstanding	7,923,000	4,694,000
Treasury stock at cost – shares	96,000	96,000
Series F and Series D Redeemable Convertible Preferred Stock [Member]
Convertible preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Convertible preferred stock, issued	118,829,000	680,047,000
Convertible preferred stock, outstanding	118,829,000	680,047,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Total revenues	$ 20,877	$ 15,789
Cost of revenues:
Total cost of revenues	12,303	8,561
Gross profit:
Total gross profit	8,574	7,228
Operating expenses:
Research and development	3,713	2,843
Sales and marketing	12,697	8,313
General and administrative	8,788	4,984
Restructuring costs		227
Total operating expenses	25,198	16,367
Loss from operations	(16,624)	(9,139)
Decrease in fair value of warrant liability		982
Other income (expense), net	(72)	(22)
Net loss before income taxes	(16,696)	(8,179)
Benefit for income taxes	2,950	0
Net Loss	(13,746)	(8,179)
Redeemable preferred stock accretion	3,691	3,513
Net loss attributable to common stockholders	$ (17,437)	$ (11,692)
Basic and diluted net loss per share (Note 15) (in Dollars per share)	$ (1.89)	$ (2.13)
Weighted-average shares of common stock used in computing basic and diluted net loss per share attributable to common stockholders (in Shares)	7,276,585	3,843,811
Recurring [Member]
Revenues:
Total revenues	$ 16,207	$ 12,210
Cost of revenues:
Total cost of revenues	5,026	2,823
Gross profit:
Total gross profit	11,181	9,387
Non-Recurring [Member]
Revenues:
Total revenues	4,670	3,579
Cost of revenues:
Total cost of revenues	7,277	5,738
Gross profit:
Total gross profit	$ (2,607)	$ (2,159)

Consolidated Statements of Rede

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Series C Preferred Stock [Member]Redeemable Preferred Stock [Member]	Series C Preferred Stock [Member]Common Stock [Member]	Series C Preferred Stock [Member]Additional Paid-in Capital [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]Redeemable Preferred Stock [Member]	Series D Preferred Stock [Member]Common Stock [Member]	Series D Preferred Stock [Member]Additional Paid-in Capital [Member]	Series D Preferred Stock [Member]	Series E Preferred Stock [Member]Redeemable Preferred Stock [Member]	Series E Preferred Stock [Member]Common Stock [Member]	Series E Preferred Stock [Member]Additional Paid-in Capital [Member]	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]Redeemable Preferred Stock [Member]	Series F Preferred Stock [Member]Additional Paid-in Capital [Member]	Series F Preferred Stock [Member]	Redeemable Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Total
Balance at Mar. 31, 2013																	$ 4	$ 267,339	$ (472)	$ (266,351)	$ 520
Balance (in Shares) at Mar. 31, 2013																	2,982,907		(95,653)
Issuance of common stock, redeemable convertible Series D preferred stock, and warrants through a private placement, net of issuance costs	$ 846		$ 1,875	$ 1,875	$ 4,499		$ 3,495	$ 3,495
Issuance of common stock, redeemable convertible Series D preferred stock, and warrants through a private placement, net of issuance costs (in Shares)	231,518	668,249			680,470	777,216
Value of benefical conversion feature in preferred stock	$ (846)		846	846	$ (1,345)		1,345	1,345
Accretion of preferred stock	228		(775)	(775)	1,892		(1,892)	(1,892)
Warrants to purchase common stock issued in connection with private placement							1,789	1,789
ESPP purchase																		257			257
ESPP purchase (in Shares)																	37,553
Issuance of restricted stock, net																		(233)			(233)
Issuance of restricted stock, net (in Shares)																	89,053
Exercise of stock options																		(19)			$ (19)
Exercise of stock options (in Shares)																	3,967				43,000
Stock-based compensation expense																		1,149			$ 1,149
Net Loss																				(8,179)	(8,179)
Conversion of preferred stock to common stock	$ (1,621)		$ 1,621	$ 1,621
Conversion of preferred stock to common stock (in Shares)	(231,518)	231,518
Reclassification of warrants from liability to equity upon modification																		1,286			1,286
Balance at Mar. 31, 2014																$ 3,653	$ 4	278,083	$ (472)	(274,530)	3,085
Balance (in Shares) at Mar. 31, 2014																680,470	4,790,463		(95,653)
Issuance of common stock, redeemable convertible Series D preferred stock, and warrants through a private placement, net of issuance costs									$ 6,419				$ 4,413
Issuance of common stock, redeemable convertible Series D preferred stock, and warrants through a private placement, net of issuance costs (in Shares)									124,891				118,829
Value of benefical conversion feature in preferred stock									$ (1,571)		$ 1,571	$ 1,571	$ (564)	$ 564	$ 564						2,135
Accretion of preferred stock									2,645		(2,645)	(2,645)	$ 1,046	(1,046)	(1,046)
Warrants to purchase common stock issued in connection with private placement											809	809		$ 678	$ 678
Beneficial conversion feature for convertible note																		100			100
ESPP purchase																		215			215
ESPP purchase (in Shares)																	48,833
Issuance of restricted stock, net																		(756)			$ (756)
Issuance of restricted stock, net (in Shares)																	238,375
Exercise of stock options (in Shares)																	1,718				2,000
Stock-based compensation expense																		2,538			$ 2,538
Net Loss																				(13,746)	(13,746)
Conversion of preferred stock to common stock					$ (3,653)		$ 3,653	$ 3,653	$ (7,493)	$ 1	$ 7,492	$ 7,493
Conversion of preferred stock to common stock (in Shares)					(680,470)	690,274			(124,891)	1,248,905
Issuance of stock in consideration of Merger																		6,610			6,610
Issuance of stock in consideration of Merger (in Shares)																	1,000,000
Balance at Mar. 31, 2015																$ 4,895	$ 5	$ 297,866	$ (472)	$ (288,276)	$ 9,123
Balance (in Shares) at Mar. 31, 2015																118,829	8,018,568		(95,653)

Consolidated Statements of Red6

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Series C Preferred Stock [Member]
Issuance costs		$ 437
Series D Preferred Stock [Member]
Issuance costs	$ 53	$ 286
Series E Preferred Stock [Member]
Issuance costs	100
Series F Preferred Stock [Member]
Issuance costs	$ 350

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net loss	$ (13,746)	$ (8,179)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,530	246
Loss on disposition of property and equipment		23
Impairment of capitalized software	340
Stock-based compensation expense	2,538	1,149
Change in fair value of warrant liability		(982)
Changes in assets and liabilities, net of business combination:
Accounts receivable (net)	421	449
Restricted cash	(34)
Prepaid expenses and other current assets	(505)	164
Other assets	(2)	9
Accounts payable	(195)	359
Accrued restructuring costs		(232)
Accrued payroll and related liabilities	(421)	(334)
Other accrued liabilities and long term liabilities	158	162
Deferred revenue	(2,989)	(2,177)
Deferred tax Liability	1,270
Net cash used in operating activities	(11,635)	(9,343)
Investing activities
Purchase of property and equipment	(51)	(121)
Capitalized software	(1,962)	(910)
Purchase of business, net of cash	(4,451)
Net cash used in investing activities	(6,464)	(1,031)
Financing activities
Proceeds from sale of common stock, preferred stock and warrants, net of issuance costs	12,319
Employee taxes paid in exchange for restricted stock awards forefeited	(578)	949
Issuance of common stock under employee stock plan	213
Credit facility borrowing, net	498
Credit facility payment	(655)	(232)
Repayment of note Payable	(277)	239
Issuance of Convertible Note, net	3,000
Issuance of cost associated with promissory note	(150)	14,227
Net cash provided by financing activities	14,370	15,183
Net increase (decrease) in cash and cash equivalents	(3,729)	4,809
Cash and cash equivalents at beginning of the period	16,907	12,098
Cash and cash equivalents at end of the period	13,178	16,907
Supplemental disclosure of cash flow information:
Cash paid for interest	35	35
Beneficial conversion feature for convertible redeemable preferred stock	2,135
Accretion of preferred series stock to redemption value	3,691	3,513
Conversion of Series D and E redeemable preferred stock to common stock	11,145	$ 1,621
Issuance of shares in business combination	6,610
Assumption of debt in connection with business combination	$ 932

Note 1 - Summary of Business

Note 1 - Summary of Business	12 Months Ended
	Mar. 31, 2015
Disclosure Text Block [Abstract]
Basis of Accounting [Text Block]	1. Summary of Business Selectica, Inc. (the “Company” or “Selectica”) is a leading provider of enterprise contract management, supply management, and configuration solutions. Since 1996, Selectica has helped global companies actively manage their contracts throughout the sales, procurement, and legal life cycle. Selectica's contract lifecycle management, strategic sourcing, and purchasing solutions drive business value by assisting organizations in managing contracts profitably, effectively accelerating revenue opportunities, and minimizing risk through compliance. Our patented technology assists customers across a myriad of industries—including high-tech, telecommunications, manufacturing, healthcare, and financial services—to accelerate and streamline contract management, sales processes, spend analysis, procurement intelligence, sourcing, and supplier lifecycle management. Selectica also provides a powerful configuration engine, which Fortune 500 companies use to increase revenue by facilitating the right combination of products, services, and price.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Policies	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. Summary of Significant Policies Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and include the accounts of the Company and our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the accounts receivable and sales allowances, fair values of financial instruments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of stock-based awards, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Change in Presentation of Financial Statements In the prior year ended March 31, 2014, the Company changed the presentation of its financial statements to include third party consulting costs related to our Selectica Configuration Solutions in its cost of sales. Previously, these costs were included in research and development expenses. Reclassifications of $0.2 million from research and development expense to recurring cost of sales were made in fiscal 2014, to conform to the current year’s presentation. This reclassification of the prior year amounts does not change the previously reported operating loss or net loss. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments, and accounts receivable. The Company places its short-term investments in high-credit quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the balance sheet. The Company’s cash balances periodically exceed the FDIC insured amounts. Accounts receivable are derived from revenue earned from customers primarily located in the United States. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral. The Company maintains reserves for potential credit losses, and historically, such losses have not been significant. Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of money market funds, certificates of deposits, and commercial paper. Fair values of cash equivalents approximated original cost due to the short period of time to maturity. The cost of securities sold is based on the specific identification method. The Company’s investment policy limits the amount of credit exposure to any one issuer of debt securities. Restricted Cash The Company’s restricted cash consist of certificates of deposits for our credit card for our office in the UK. Accounts Receivable, Net of Allowance for Doubtful Accounts The Company evaluates the collectability of its accounts receivable based on a combination of factors. When the Company believes a collectability issue exists with respect to a specific receivable, the Company records an allowance to reduce that receivable to the amount that it believes to be collectible. In making the evaluations, the Company will consider the collection history with the customer, the customer’s credit rating, communications with the customer as to reasons for the delay in payment, disputes or claims filed by the customer, warranty claims, non-responsiveness of customers to collection calls, and feedback from the responsible sales contact. In addition, the Company will also consider general economic conditions, the age of the receivable and the quality of the collection efforts. Property and Equipment, Net Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on estimated useful lives. The estimated useful lives for computer software and equipment is three years, furniture and fixtures is five years, and leasehold improvements is the shorter of the lease term or estimated useful life. Business Combinations The Company accounts for acquisitions using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805 - Business Combinations. relationships and acquired patents and developed technology; and discount rates. Management’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Intangible Assets and Impairment of Long-Lived Assets Intangible assets consist of customer relationships, trade names, and acquired technology. Intangible assets are recorded at fair values at the date of the acquisition and, for those assets having finite useful lives, are amortized using the straight-line method over their estimated useful lives, which generally range from two to five years. The Company periodically reviews its intangible and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company then compares the carrying amounts of the assets with the future net undiscounted cash flows expected to be generated by such asset. Should an impairment exist, the impairment loss would be measured based on the excess carrying value of the asset over the asset’s fair value determined using discounted estimates of future cash flows. There was no impairment charge recorded during the year ended March 31, 2015. Goodwill Goodwill represents the excess of the purchase consideration over the net tangible and an identifiable intangible asset acquired in a business combination and is allocated to reporting units expected to benefit from the business combination. The Company tests goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the assets may be impaired. The Company has elected to first assess certain qualitative factors to determine whether it is more likely than not that the fair value of its single reporting operating unit is less than the carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. If the Company determines that it is more likely than not that the fair value is less than its carrying amount, then the two-step goodwill impairment test will be performed. The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step will be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value. There was no impairment charge recorded during the year ended March 31, 2015. Customer Concentrations A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years: Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer A 10 % 14 % Customers who accounted for at least 10% of gross accounts receivable were as follows: Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer B 15 % 29 % Revenue Recognition The Company generates revenues by providing its software as a service solutions through subscription license arrangements and related professional services, as well as through perpetual and term licenses and related software maintenance and professional services. The Company presents revenue net of sales taxes and any similar assessments. Revenue recognition criteria the Company determines that any one of the four criteria is not met, the Company will defer recognition of revenue until all the criteria are met. Multiple-Deliverable Arrangements. Upon separating the multiple-deliverables into separate units of accounting, the arrangement consideration is allocated to the identified separate units based on a relative selling price hierarchy. The Company determines the relative selling price for a deliverable based on its vendor-specific objective evidence of selling price (“VSOE”), if available, or its best estimate of selling price (“BESP”), if VSOE is not available. The Company has determined that third-party evidence of selling price (“TPE”) is not a practical alternative due to differences in its service offerings compared to other parties and the availability of relevant third-party pricing information. The amount of revenue allocated to delivered items is limited by contingent revenue, if any. For professional services and subscription services, the Company has not established VSOE due to lack of pricing consistency, and other factors. Accordingly, the Company uses its BESP to determine the relative selling price. The Company determined BESP by considering its price list, as well as overall pricing objectives and market conditions. Significant pricing practices taken into consideration include the Company’s discounting practices, contract prices per user, the size and volume of the Company’s transactions, the customer demographic, and its market strategy. Recurring revenues. Non-recurring revenues. In certain arrangements with non-standard acceptance criteria, the Company defers the revenue until the acceptance criteria are satisfied. Reimbursements, including those related to travel and out-of-pocket expenses are included in non-recurring revenues, and an equivalent amount of reimbursable expenses is included in non-recurring cost of revenues. Advertising Expense The cost of advertising is expensed as incurred. Advertising expense for the years ended March 31, 2015 and 2014 was approximately $614,000 and $209,000 respectively. Foreign Currency The Company’s UK subsidiary’s functional currency is the U.S. dollar. Non-monetary assets and liabilities are translated into U.S. dollar equivalents at the exchange rate in effect on the balance sheet date and revenues and expenses are translated into U.S. dollars using the average exchange rate over the period. The net gains and losses resulting from foreign exchange transactions are recorded in other income (expense), net in the condensed consolidated statement of operations. Capitalized Software Development Costs Software development costs incurred prior to the establishment of technological feasibility are included in research and development expenses. The Company defines achievement of technological feasibility as the completion of a working model. Software development costs incurred subsequent to the establishment of technological feasibility through the period of general market availability of the products are capitalized, if material, after consideration of various factors, including net realizable value. Capitalized software costs are amortized once the product is available for general release, using the straight-line method over the estimated useful lives of the asset. Capitalized software developments costs are evaluated for recoverability based on estimated future gross revenues reduced by the associated costs. If gross revenues were to be significantly less than estimated, the net realizable value of the capitalized software would be considered impaired, which could result in the write-off of all or a portion of the unamortized balance of such capitalized software. During the years ended March 31, 2015 and 2014, the Company recorded impairment charges of $0.3 million and $0, respectively, related to our capitalized software development costs. These impairment charges are included in R&D expenses in the accompanying consolidated statements of operations (see Note 7). Stock-Based Compensation The Company recognizes stock-based compensation expense for only those awards ultimately expected to vest on a straight-line basis over the requisite service period of the award, net of an estimated forfeiture rate. The Company estimates the fair value of stock options using a Black-Scholes valuation model, which requires the input of highly subjective assumptions, including the option’s expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, its stock-based compensation expense could be materially different in the future. Geographic Information: International revenues are attributable to countries based on the location of the customers. For the fiscal years ended March 31, 2015 and 2014, sales to international locations were derived primarily from Canada, India, New Zealand, Switzerland, Germany, Hong Kong, Ireland, Norway and the United Kingdom. Fiscal Years Ended March 31, 2015 2014 (in thousands, except percentages) International Revenues 13 % 10 % Domestic Revenues 87 % 90 % Total Revenues 100 % 100 % For the years ended March 31, 2015 and 2014, the Company held long-lived assets outside of the United States with a net book value of approximately $47,000 and $67,000, respectively. These assets were located in Odessa, Ukraine. Treasury Stock There were no stock repurchases during the fiscal year ended 2015 and 2014. The Company had 96,000 shares of treasury stock as of March 31, 2015 and March 31, 2014. Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (the “FASB”) issued ASU 2015-05, Intangibles − Goodwill and Other − Internal-use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement, In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In February 2015, the FASB issued ASU 2015-02, Consolidation (Subtopic 810): Amendments to the Consolidation Analysis In May 2014, the FASB issued ASC 2014-09, Revenue from Contracts with Customers (Subtopic 606),

Note 3 - Acquisition

Note 3 - Acquisition	12 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	3. Acquisition Iasta.com, Inc. and Iasta Resources, Inc. On July 2, 2014, the Company completed its acquisition of Iasta.com, Inc., an Indiana corporation, and Iasta Resources, Inc., an Indiana corporation (together, “Iasta”). Pursuant to the Agreement and Plan of Merger dated June 2, 2014, among the Company, Selectica Sourcing, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Selectica Sourcing”), Iasta and Iasta’s shareholders, Iasta merged with and into Selectica Sourcing, with Selectica Sourcing continuing as a wholly owned subsidiary of the Company. The acquisition of Iasta positions the Company to provide easier access to contract management, strategic sourcing, spend management and Configuration solutions, and increases the Company’s market coverage in more locations worldwide to its customers. The total purchase price for Iasta included 1,000,000 shares of the Company’s common stock valued at $6.6 million, and cash of $6.5 million, adjusted for amounts related to the repayment of $0.7 million for outstanding borrowings under a line of credit, $0.3 million related to a note payable and payment of transaction costs and certain other adjustments. The total purchase price is subject to a $1.4 million cash escrow (the “Escrow”) to cover any post-closing adjustments and indemnification obligations of the former Iasta shareholders. A portion of the Escrow will be released on the 12-month anniversary of the closing of the acquisition, and the remainder of the Escrow will be released on the 18-month anniversary of the closing. Concurrent with the closing of the acquisition, the Company entered into employment agreements with certain key employees of Iasta. In addition, the Company granted options to certain employees of Iasta to purchase up to 700,000 shares of the Company’s common stock. The assets acquired and liabilities assumed in connection with the acquisition of Iasta were recorded at their fair values as of the acquisition date. The total purchase price was comprised of the following: (in thousands) Cash Paid $ 6,494 Total Stock value 6,610 Working Capital Adjustment $ (734 ) Total Purchase Price $ 12,370 Summary (in thousands) Cash $ 1,491 Restricted cash 139 Accounts receivable 2,618 Prepaid and other Assets 314 Fixed assets, net 188 Customer relationships 4,210 Developed technology 3,170 Trade name 120 Goodwill 7,702 Other long term assets 340 Accounts payable and accrued expenses (562 ) Accrued and payroll benefits (688 ) Credit facility (655 ) Notes payable (277 ) Other current liabilities (718 ) Deferred revenue (2,033 ) Deferred tax asset - current 280 Deferred tax liability - non current (3,269 ) Total value of assets acquired and liabilities assumed $ 12,370 The purchase price allocation includes goodwill of $7.7 million, which is primarily attributable to the synergies expected to arise after the acquisition and fair value of assembled workforce. The Company incurred $0.4 million of transactional costs which is recorded as part of General and Administrative expenses during the year ended March 31, 2015. The acquired working capital has been finalized and impacted goodwill balance post acquisition date. The goodwill is not deductible for income tax purposes. Unaudited Pro Forma Financial Information The unaudited pro forma financial information in the table below summarizes the combined results of operations for the Company and Iasta, which was considered a “significant” acquisition (as defined in Regulation S-X) for the purposes of unaudited pro forma financial information disclosure, as though the companies were combined as of April 1, 2013. The pro forma financial information for all periods presented also includes the business combination accounting effects resulting from the Iasta acquisition including amortization charges from acquired intangible assets and stock-based compensation charges for unvested stock option awards, as though the Company and Iasta were combined as of April 1, 2013. The related tax effect was insignificant. The pro forma financial information, as presented below, is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition of Iasta had taken place as of the beginning of each period presented. T he pro forma financial information does not reflect the impact of any reorganization or operating efficiencies resulting from combining the two companies. The historical financial information has been adjusted to give effect to the pro forma events that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated financial information reflects assuming the acquisition had occurred on April 1, 2013 . Acquisition related expenses are primarily included in general and administrative expenses. 2015 2014 (thousands, except per share data) Revenue $ 23,796 $ 26,271 Loss from operations $ (16,769 ) $ (9,139 ) Net Loss $ (13,952 ) $ (8,179 ) Basic and diluted net loss per share $ (1.92 ) $ (2.13 ) Finalization of preliminary purchase price allocation Under U.S. GAAP, the period that is allowed for finalizing the identification and measurement of the fair value of the assets acquired and the liabilities assumed in a business combination ends when the acquiring entity is no longer waiting for information that it has arranged to obtain and that is known to be available or obtainable. At March 31, 2015, the Company determined that its measurement and recognition of assets acquired and liabilities assumed in the Iasta acquisition was recorded on a final basis.

Note 4 - Goodwill and Purchased

Note 4 - Goodwill and Purchased Intangible Assets	12 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	4. Goodwill and Purchased Intangible Assets The following is a summary of goodwill (in thousands): (in thousands) Balance at beginning of fiscal year $ - Goodwill acquired 8,436 Working Capital Adjustment $ (734 ) Balance at end of fiscal year $ 7,702 The following is a summary of purchased intangible assets (in thousands): March 31, 2015 Gross Accumulated Net Carrying Amortization Carrying Amount Value Acquired developed technology $ 3,170 $ 476 $ 2,694 Customer relationships 4,210 526 3,684 Trade name 120 45 75 $ 7,500 $ 1,047 $ 6,453 Acquired developed technology, customer relationships, and trade name are being amortized on a straight-line basis and have weighted-average remaining useful lives of 4.25 years, 5.25 years, and 1.25 years, respectively, as of March 31, 2015. Amortization expense was $1.0 million and $0 for the years ended March 31, 2015 and 2014, respectively. As of March 31, 2015, amortization expense for intangible assets for each of the next five years is as follows: Year ended March 31: (in thousands) 2016 $ 1,396 2017 1,351 2018 1,336 2019 1,336 2020 919 Thereafter 115 Total $ 6,453

Note 5 - Private Placement Fund

Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants	12 Months Ended
	Mar. 31, 2015
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants [Abstract]
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants [Text Block]	5. Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants On January 24, 2014, in connection with the closing of a private placement equity financing (the “January 2014 Financing”), the Company sold and issued 765,605 shares of its common stock and 68,047 shares of its newly created Series D Convertible Preferred Stock, par value $0.0001 per share (“Series D Stock”) to certain institutional funds and other accredited investors at a purchase price of $6.00 per share of common stock and $60.00 per whole share of Series D Stock (or $6.00 per one-tenth of a share of Series D Stock). In addition, the Company issued to such investors warrants to purchase common stock, initially exercisable for an aggregate of 723,030 shares (the “January 2014 Warrants”). The exercise price of the January 2014 Warrants is $7.00 per share. The January 2014 Warrants have a five-year term and became exercisable on July 24, 2014, six months following the date of issuance. In connection with the January 2014 Financing, the Company issued to Lake Street Capital Markets, LLC (“Lake Street”), who served as the placement agent in such financing, 11,029 shares of common stock, 980.4 shares of Series D Stock, and a warrant to purchase 10,416 shares of common stock. In addition, on July 2, 2014, the Company completed a private placement equity financing (the “2014 Second Financing”) with certain institutional and other accredited investors, pursuant to a Purchase Agreement, dated June 5, 2014, in which such investors purchased 124,890.5 shares of Series E Convertible Preferred Stock, par value $0.0001 per share (the “Series E Stock”), at a purchase price of $60.00 per whole share (or $6.00 per one-tenth of a share of Series E Stock). In addition, the Company issued to such investors warrants to purchase common stock, initially exercisable for an aggregate of 312,223 shares of common stock (the “July 2014 Warrants”). The exercise price of the July 2014 Warrants is $7.00 per share. The July 2014 Warrants have a five-year term and became exercisable upon stockholder approval on August 27, 2014. The total proceeds raised in the 2014 Second Financing equal approximately $7.5 million. In connection with the July 2014 Financing, the Company issued to Lake Street, who served as the placement agent in such financing, a warrant to purchase 37,467 shares of common stock. The estimated relative fair value of the warrants using the Black-Scholes valuation model at the issuance date is $0.8 million. In addition, on February 6, 2015, pursuant to the terms of a Purchase Agreement, dated February 6, 2015 among the Company and certain institutional funds and other accredited investors, the Company sold and issued 118,829.1 shares of Series F Convertible Preferred Stock, par value $0.0001 per share (the “Series F Stock”) to such investors at a purchase price of $47.00 per whole share of Series F Stock (or $4.70 per one-tenth of a share of Series F Stock), for an aggregate gross purchase price of approximately $5.6 million (the “2015 Financing”). In addition to the issuance of the Series F Stock, the Company issued to each investor a warrant to purchase common stock, initially exercisable for an aggregate of 32,975 shares of common stock (the “2015 Warrants”). The exercise price of the 2015 Warrants is $6.00 per share. The 2015 Warrants have a five-year term and became exercisable upon stockholder approval on May 5, 2015. The estimated fair value of the warrants using the Black-Scholes valuation model at the issuance date is $777,500. The total proceeds raised in the 2015 Financing equal approximately $5.6 million. The holders of Series F Stock had the right to vote together with the holders of the Company’s Common Stock as a single class on any matter on which the holders of Common Stock were entitled to vote, except that the holders of Series F Stock were not eligible to vote their shares of Series F Stock on the proposal submitted to the Company’s stockholders for approval of the issuance and sale of the securities in the 2015 Financing and the conversion of the Series F Stock. Holders of Series F Stock were entitled to cast a fraction of one vote for each share of Common Stock issuable to such holder on the record date for the determination of stockholders entitled to vote at a conversion rate the numerator of which was $47.00 and the denominator of which was the closing bid price per share of the Common Stock on February 5, 2015. (a) Presentation of January 2014, July 2014 and 2015 Warrants The Company has evaluated the January 2014 Warrants, the July 2014 Warrants and the 2015 Warrants and has concluded that equity classification is appropriate as all such January 2014 Warrants, July 2014 Warrants and 2015 Warrants are considered to be indexed to the Company’s equity and there are no settlement provisions that would result in classification as a debt instrument. Such warrants are included in stockholders’ equity and are not subject to remeasurement. (b) Presentation of Redeemable Convertible Preferred Stock On April 10, 2014, following approval by the Company’s stockholders, each whole share of Series D Stock converted automatically into ten shares of common stock at an initial conversion price of $6.00 per share of common stock, for a total of 690,274 shares of common stock issued upon such conversion (including the conversion of the shares of Series D Stock issued to Lake Street as described above). Because the Series E Stock was redeemable at the option of the holder (had the stockholders not approved conversion), the Company recorded the Series E Stock in temporary equity until conversion on August 27, 2014 when the redemption value of $7.5 million was reclassified to stockholders’ equity. On August 27, 2014, following approval by the Company’s stockholders, each whole share of Series E Stock converted automatically into ten shares of common stock at an initial conversion price of $6.00 per share of common stock, for a total of 1,248,905 shares of common stock issued upon such conversion. On May 5, 2015, following approval by the Company’s stockholders, each whole share of Series F Stock converted automatically into ten shares of common stock at an initial conversion price of $4.70 per share of common stock, for a total of 1,188,291 shares of Common Stock issued upon such conversion. Because the Series F Stock was redeemable at the option of the holder (prior to the stockholders approving conversion on May 5, 2015 as discussed above), we have recorded it in temporary equity as of March 31, 2015. (c) Beneficial Conversion Feature (“BCF”) The Series E and Series F Stock were assessed under Accounting Standards Codification (“ASC”) 470, Debt (d) Carrying Values The proceeds of the July 2014 Financing and the 2015 Financing for were allocated to the common stock, the January 2014 Warrants, July 2014 Warrants and Series E Stock and Series F Stock based on their estimated relative fair values. The proceeds of the Series E Stock were allocated to the 2015 Warrants and Series F stock based on their estimated relative fair values. Carrying value of Series D Stock as of March 31, 2014 $ 3,653 Conversion of Series D stock into common stock (3,653 ) Carrying value of Series D Stock as of June 30, 2014 $ - Gross proceeds on July 2, 2014 $ 7,493 Fair value of warrants on July 2,2014 (809 ) Gross proceeds allocated to Series E Stock sold on July 2, 2014 6,684 Related transaction costs allocated (265 ) Net value allocated to Series E Stock sold prior to BCF 6,419 Calculated BCF value (1,571 ) Accretion of Series E Stock through August 27, 2014 2,645 Carrying value of Series D Stock as of August 27, 2014 7,493 Conversion of Series D stock into common stock (7,493 ) Carrying value of Series D Stock as of September 30, 2014 $ - Gross proceeds on February 5, 2015 $ 5,585 Fair value of warrants on January 5, 2015 (682 ) Gross proceeds allocated to Series F Stock sold on February 5, 2015 4,903 Related transaction costs allocated (490 ) Net value allocated to Series F Stock sold prior to BCF 4,413 Calculated BCF value (564 ) Accretion of Series E Stock through March 31, 2015 1,046 Carrying value of Series F Stock as of March 31, 2015 $ 4,895

Note 6 - Property and Equipment

Note 6 - Property and Equipment, Net	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	6 Property and Equipment , net Property and equipment consist of the following: March 31, 2015 2014 (in thousands) Computers and software $ 562 $ 2,381 Furniture and equipment 260 774 Leasehold improvements 70 117 892 3,272 Less: accumulated depreciation (602 ) (2,960 ) Total property and equipment, net $ 290 $ 312 Depreciation expense related to property and equipment was approximately $262,000 and $158,000 for the years ended March 31, 2015 and 2014, respectively.

Note 7 - Capitalized Software

Note 7 - Capitalized Software	12 Months Ended
	Mar. 31, 2015
Research and Development [Abstract]
Research, Development, and Computer Software Disclosure [Text Block]	7 . Capitalized Software The Company capitalizes software development costs upon achieving technological feasibility of the related products. Software development costs incurred prior to achieving technological feasibility are charged to engineering and product development expense as incurred. Capitalized software will be amortized once the product is available for general release, using the straight-line method over the estimated useful lives of the assets, which is three years. The recoverability of capitalized software is evaluated for recoverability based on estimated future gross revenues reduced by the associated costs. If gross revenues were to be significantly less than estimated, the net realizable value of the capitalized software intended for sale would be impaired, which could result in the write-off of all or a portion of the unamortized balance of such capitalized software. The Company recognized $0.3 million of impairment charges for capitalized software in the year ended March 31, 2015. Amortization expense was $0.6 million and $0.01 million for the years ended March 31, 2015 and 2014, respectively, and is included in the product cost of revenue. The unamortized balance of capitalized software was $2.3 million and $0.9 million as of March 31, 2015 and 2014, respectively.

Note 8 - Balance Sheet Componen

Note 8 - Balance Sheet Components	12 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Supplemental Balance Sheet Disclosures [Text Block]	8 . Balance Sheet Components As of March 31, 2015 and 2014, accrued payroll and related liabilities, other accrued liabilities and deferred revenue consisted of the following: 2015 2014 (in thousands) Accrued payroll and related liabilities: Accrued vacation $ 561 $ 371 Accrued bonus 83 164 Accrued wages — — Accrued benefits 97 92 Accrued commissions 169 21 Total $ 910 $ 648 2015 2014 (in thousands) Other accrued liabilities: Accrued accounts payable $ 783 $ 150 VAT on sales 125 — Employee withhold tax for stock 227 19 Sales tax payable 662 76 Other accrued liabilities 80 100 Total $ 1,877 $ 345 2015 2014 (in thousands) Deferred revenue: $ $ Hosting 90 85 Consulting 656 138 Training 8 — Subscription 5,457 2,650 Maintenance 2,215 2,876 Other 6 — Total $ 8,432 $ 5,749

Note 9 - Operating Lease Commit

Note 9 - Operating Lease Commitments	12 Months Ended
	Mar. 31, 2015
Leases, Operating [Abstract]
Operating Leases of Lessor Disclosure [Text Block]	9. Operating Lease Commitments On May 15, 2014, the Company entered into a First Amendment to Lease (the “Lease Amendment”) with SKBGS I, L.L.C. amending the Office Lease dated July 8, 2011, whereby the Company is leasing approximately 10,516 square feet of office space at a premises located at 2121 South El Camino Real, Suite 1000, San Mateo, California, where the Company maintains its headquarters. The Lease Amendment extends the lease term to cover a 25-month period expiring January 31, 2017 and carries a base rent of $2.85 per rentable square foot, escalating 3% each year. In connection with the acquisition of Iasta, we assumed lease for offices in Carmel, Indiana and in London, United Kingdom. The lease in Indiana, dated January 7, 2008 and as amended June 5, 2009, is for approximately 9,948 square feet of office space, expires April 13, 2016 and carries a base rent of $1.80 per rentable square foot, escalating 9% in the last two years of the lease. Rental expenses for the office space and equipment were approximately $0.7 million and $0.2 million for years ended March 31, 2015 and 2014 respectively. Minimum payments under our operating leases agreements are $0.6 million in fiscal 2016 and $0.3 million in fiscal 2017.

Note 10 - Contingencies

Note 10 - Contingencies	12 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Legal Matters and Contingencies [Text Block]	10. Contingencies Warranties and Indemnifications The Company’s products are generally warranted to perform substantially in accordance with the functional specifications set forth in the associated product documentation for a period of 90 days. In the event there is a failure of such warranties, the Company generally is obligated to correct the product to conform to the product documentation or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product or service. The Company has not provided for a warranty accrual as of March 31, 2015 and 2014. To date, the Company has not refunded any amounts in relation to the warranty. The Company generally agrees to indemnify its customers against legal claims that the Company’s software infringes certain third-party intellectual property rights. In the event of such a claim, the Company is obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of the infringement, the Company agrees to modify or replace the infringing product, or, if those options are not reasonably possible, to refund the purchase price of the software. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers. As such, the Company has not provided for an indemnification accrual as of March 31, 2015 and 2014.

Note 11 - Convertible Notes

Note 11 - Convertible Notes	12 Months Ended
	Mar. 31, 2015
Convertible Debt [Abstract]
Convertible Debt [Text Block]	11. Convertible Notes On March 11, 2015, the Company entered into a Junior Secured Convertible Note Purchase Agreement with Lloyd I. Miller, III (“Mr. Miller”), the Company’s largest stockholder, and two of his affiliates: MILFAM II L.P. (“MILFAM”) and Lloyd I. Miller Trust A-4 (collectively, the “Miller Group”), pursuant to which the Company issued and sold junior secured convertible promissory notes (the “Convertible Notes”) to the Miller Group in the aggregate principal amount of $3 million. The Convertible Notes are due on March 11, 2020, and accrue interest at an annual rate of 8% on the aggregate unconverted and outstanding principal amount, payable quarterly. The Company also has the option to pay any amounts of interest due under the Notes by converting such interest into shares of common stock of the Company at a conversion price of $5.70 per share (as may be adjusted for stock splits, recapitalizations or other similar events), based upon an interest rate amount calculated at 10% per year, provided that the Company provides prior written notice thereof to the Miller Group at least 10 days in advance of the applicable interest payment date. The Convertible Notes may be converted into shares of Common Stock at the sole option of the Miller Group at any time and from time to time after May 5, 2015 and prior to the Maturity Date, at a conversion price of $5.70 (as may be adjusted for stock splits, recapitalizations or other similar events). Following the issuance of the Convertible Notes, the Company filed a registration statement with the Securities and Exchange Commission with respect to the common stock issuable pursuant to conversion of the Convertible Notes. The Convertible Notes may not be prepaid or called by the Company prior to the Maturity Date. The Convertible Notes are secured by a junior security interest on the Company’s assets, subordinate only to the senior security interest of the Company’s institutional lender, Bridge Bank, N.A. The Company evaluated the agreement per the guidance at ASC 470-50-40-10, and determined that the present value of the cash flows under the terms of the Convertible Notes agreement did not differ by more than 10% from the present value of the remaining cash flows of the original notes. Therefore, debt extinguishment accounting rules do not apply. Upon any default under the Convertible Notes, the Convertible Notes will bear interest at the rate of 13% per year, or, if less, the maximum rate allowable under the laws of the State of New York. The Company calculated $0.1 million for the intrinsic value of the beneficial conversion feature (“BCF”) of the Convertible Notes of $0.19, based on the last sales price per share, and recorded the $0.1 million BCF as a debt discount and as additional paid-in-capital. The note discount is being amortized to interest expense over the term of the Convertible Notes. For the year ended March 31, 2015, $3,000 of BCF debt discount was amortized to interest expense. The Company recorded $0.2 million of debt issuance costs associated with the agreement described above as part of Other long-term liabilities at March 31, 2015.

Note 12 - Credit Facility

Note 12 - Credit Facility	12 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	1 2 . Credit Facility On March 11, 2015, the Company entered into Amendment Number Two to Amended and Restated Business Financing Agreement, which amended the Business Financing Agreement entered into with Bridge Bank, National Association (“Bridge Bank”) on July 25, 2014, as amended on December 31, 2014 (as amended, the “Credit Facility”). The Credit Facility provides a revolving receivables financing facility in an amount up to $5.0 million (the “Receivables Financing Facility”) and a revolving cash secured financing facility in an amount up to $4.0 million (the “Working Capital Facility”), for an aggregate revolving credit facility of up to $9.0 million. The Receivables Financing Facility may be drawn in amounts up to $5.0 million in the aggregate, subject to a minimum borrowing base requirement equal to 80% of the Company’s eligible accounts receivable as determined under the Credit Facility. The Working Capital Facility may be drawn in such amounts as requested by the Company, not to exceed $4.0 million in the aggregate. The Credit Facility terminates on March 20, 2016, provided, however, that in the event of an early termination by the Company, a penalty of 1.0% of the total credit facility would be triggered. All amounts borrowed under the Credit Facility are secured by a general security interest on the assets of the Company and are subject to a 2.00 Current Ratio of (i) cash and cash equivalents plus all eligible receivables in relation to (ii) the Company’s current liabilities excluding current deferred revenue. Except as otherwise set forth in the Credit Facility, borrowings made under the Receivables Financing Facility will bear interest at a rate equal to the prime rate or 3.25%, whichever is greater, plus 0.25%, and borrowings made under the Working Capital Facility will bear interest at a rate equal to the financial institution’s certificate of deposit 30-day rate plus 200 basis points, with the total minimum monthly interest to be charged being $2,000. As of March 31, 2015 and March 31, 2014, the Company owed $7.4 million and $6.9 million, respectively, under the Credit Facility, and no amounts were available for future borrowings. In order to satisfy certain conditions for Bridge Bank to lend additional funds under the Credit Facility, on March 11, 2014, Mr. Miller and MILFAM each entered into a Limited Guaranty (the “Guaranties”) with Bridge Bank to provide a limited, non-revocable guaranty of the Company’s Credit Facility in the amount of $1 million each, for a total guaranteed amount of $2 million. The term of the Guaranties is two years. Bridge Bank, in its sole discretion, may reduce, but not increase, the guaranteed amount under the Guaranties during the term. In connection with the Guaranties, on March 11, 2015, the Company entered into a Guaranty Fee Agreement with Mr. Miller and MILFAM, pursuant to which the Company agreed to pay Mr. Miller and MILFAM an aggregate commitment fee of $100,000 and a monthly fee equal to (i) 1% of the loan amount then guaranteed under the Guaranties for the first 12 months of the term and (ii) 1.5% of the loan amount then guaranteed under the Guaranties for the second 12 months of the term. The commitment fee and the aggregate amount of the monthly fees are payable in cash by the Company within five business days following the termination or expiration of the Guaranties. The Company recorded $0.2 million of fees associated with the Guaranty Fee Agreement as part of Other long-term liabilities at March 31, 2015.

Note 13 - Stockholders' Equity

Note 13 - Stockholders' Equity	12 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	13. Stockholders’ Equity Common Stock Reserved for Future Issuance At March 31, 2015, shares of common stock reserved for future issuance of stock-based grants were as follows: Equity incentive plans: Awards outstanding 348,386 Options outstanding 1,099,323 Reserved for future grants 563,000 Total common stock reserved for future issuance 2,010,709 The effect of recording stock-based compensation expense (including expense related to the Employee Stock Purchase Plan (“ESPP”) discussed below) for each of the periods presented was as follows (in thousands): Fiscal years Ended March 31, (in thousands) 2015 2014 Cost of revenues $ 459 $ 250 Research and development 213 167 Sales and marketing 836 345 General and administrative 1,030 385 Impact on net loss $ 2,538 $ 1,149 Upon the departures of our CEO and COO in August 2013, previously recognized stock-based compensation 1999 ESPP The price paid for the Company’s common stock purchased under the ESPP is equal to 85% of the lower of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each offering period. The compensation expense in connection with the ESPP for the fiscal years ended March 31, 2015 and 2014 was $80,000 and $114,000, respectively. During the fiscal years ended March 31, 2015 and 2014, there were 48,833 and 37,533 shares issued under the ESPP. Stock Option Plans—Approved by Stockholders 1996 Plan The Company adopted the 1996 Stock Plan as amended and restated March 28, 2001 (the “1996 Plan”). A total of approximately 815,000 shares of common stock have been reserved under the 1996 Plan. With limited restrictions, if shares awarded under the 1996 Plan are forfeited, those shares will again become available for new awards under the 1996 Plan. The 1996 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986, and non-statutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the board and consultants are eligible to participate in the 1996 Plan. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and non-statutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1996 Plan have a maximum term of ten years. 1999 Equity Incentive Plan The Company adopted the 1999 Equity Incentive Plan (the “1999 Plan”) on November 18, 1999. The 1999 Plan was amended in May 2010, such that the number of shares reserved for issuance is no longer automatically increased, and a total of 1,551,000 shares were reserved for future issuance. With limited restrictions, if shares awarded under the 1999 Plan are forfeited, those shares will again become available for new awards under the 1999 Plan. The 1999 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986 and non-statutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the Board of Directors and consultants are eligible to participate in the 1999 Plan. Each eligible participant is limited to being granted options or stock appreciation rights covering no more than 33,000 shares per fiscal year, except in the first year of employment where the limit is 66,000 shares. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and non-statutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1999 Plan have a maximum term of ten years. On December 3, 2012, the Compensation Committee of the Board of Directors of the Company adopted a Long Term Performance Incentive Plan (the “LTPIP”) within the 1999 Equity Incentive Plan (the “1999 Plan”), under which restricted stock units would be granted to the Company’s executives. Under the LTPIP, sixty percent (60%) of the restricted stock units will vest based upon achievement of contracted monthly recurring revenue targets over a period of three years, with fifty percent (50%) of the amount withheld from vesting until the Company achieves profitability, and forty percent (40%) vest based upon operating profit targets over a period of three years. The restricted stock units granted under the LTPIP include 420,000 shares granted to the Company’s executives, under which the Company’s Chief Executive Officer received a grant of 220,000 restricted stock units, and the Company’s Chief Financial Officer, Chief Strategy Officer, Chief Operating Officer and Chief Commercial Officer each received a grant of 50,000 restricted stock units. The Company is amortizing the related compensation expense on a straight-line basis over the expected vesting period. The compensation expense was $0.1 million for the year ended March 31, 2015 and $0.4 million for the year ended March 31, 2014. 1999 ESPP On November 18, 1999, the Company’s Board of Directors approved the adoption of the 1999 Employee Stock Purchase Plan (the “Purchase Plan”) and the Company’s stockholders have approved of the Purchase Plan. The Purchase Plan was amended and restated on February 1, 2008 and amended and restated on November 7, 2012. A total of 100,000 shares of common stock were initially reserved for issuance under the Purchase Plan. The November 7, 2012 amendment and restatement of the Purchase Plan provided a reserve of 553,000 shares of common stock available for issuance under the Purchase Plan. The Compensation Committee of the Board of Directors administers this plan. The Purchase Plan is intended to qualify under Section 423 of the Internal Revenue Code. The Purchase Plan permits eligible employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s cash compensation, at a purchase price equal to the lower of 85% of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each purchase period. Employees who work more than five months per year and more than twenty hours per week are eligible to participate in the Purchase Plan. Stockholders who own more than 5% of the Company’s outstanding common stock are excluded from participating in the Purchase Plan. Each eligible employee cannot purchase more than 5,000 shares per purchase date (10,000 shares per year) and, generally, cannot purchase more than $25,000 of stock per calendar year. Eligible employees may begin participating in the Purchase Plan at the start of an offering period. Each offering period lasts six months beginning on January 31 and July 31 of each calendar year with an additional one-time offering period beginning on or about November 1, 2012 and terminating on or about January 1, 2013. Employees may end their participation in the Purchase Plan at any time. Participation ends automatically upon termination of employment. The Board of Directors may amend or terminate the Purchase Plan at any time. If not terminated earlier, the Purchase Plan has a term of twenty years. If the Board of Directors increases the number of shares of common stock reserved for issuance under the Purchase Plan, other than any share increase resulting from the formula described in the previous paragraph, it must seek the approval of the Company’s stockholders. 2001 Supplemental Plan We adopted the 2001 Supplemental Plan (the “Supplemental Plan”) on May 30, 2001; the Supplemental Plan did not require stockholder approval. A total of approximately 250,000 shares of common stock have been reserved for issuance under the Supplemental Plan. With limited restrictions, if shares awarded under the Supplemental Plan are forfeited, those shares will again become available for new awards under the Supplemental Plan. The Supplemental Plan permits the grant of non-statutory options and shares of restricted stock. Employees and consultants, who are not officers or members of the Board of Directors, are eligible to participate in the Supplemental Plan. Options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the Supplemental Plan have a maximum term of ten years. The following tables summarize activity under the equity incentive plans: Options Outstanding Restricted Stock Units Outstanding Number of shares (in thousands) Weighted average exercise price Number of shares (in thousands) Weighted average fair value Outstanding at March 31, 2013 161 $ 7.76 724 $ 5.53 Granted 316 $ 6.28 530 $ 6.91 Granted outside of plan $ 6.85 Exercised (43 ) $ 5.32 (122 ) $ 5.72 Cancelled (48 ) $ 11.14 (493 ) Outstanding at March 31, 2014 386 $ 6.40 639 $ 6.88 Granted 61 $ 5.86 234 $ 5.93 Granted outside of plan 700 $ 6.61 - - Exercised (2 ) $ 3.70 (362 ) $ 6.32 Cancelled (46 ) $ 7.50 (163 ) $ 6.43 Outstanding at March 31, 2015 1,099 $ 6.46 348 $ 6.18 Vested and expected to vest 987 $ 6.45 Shares Available for Grant Balance at March 31, 2013 673 Options: Shares added 187 Granted – approved plan (316 ) Cancelled 48 Restricted Stock Units: Granted (530 ) Cancelled 493 Balance at March 31, 2014 556 Options: Granted – approved plan (61 ) Cancelled 10 Restricted Stock Units: Granted (234 ) Cancelled 163 Released shares repurchased 129 Balance at March 31, 2015 563 The options outstanding and exercisable at March 31, 2015 were in the following exercise price ranges: Options Outstanding Options Vested and Exercisable Range of Exercise Number Weighted- Number Weighted- Prices Per Share of Shares Average of Shares Average (in thousands) Remaining (in thousands) Exercise Price Contractual Per Share Life (Years) $3.70 - $5.72 103 6.49 90 $ 6.2 $5.83 - $6.28 61 9.46 13 $ 9.43 $6.28 - $6.83 187 8.68 58 $ 8.68 $6.30 - $34.00 748 9.12 69 $ 7.89 $3.70 - $34.00 1,099 $ 6.46 230 $ 6.18 The weighted average remaining contractual term for exercisable options is 7.52 years. The intrinsic value is calculated as the difference between the market value as of March 31, 2015 and the exercise price of the shares. The market value of the Company’s common stock as of March 31, 2015 was $6.50. The aggregate intrinsic value of stock options outstanding at March 31, 2015 and 2014 was $198,000 and $219,000, respectively. The aggregate intrinsic value of restricted stock units outstanding at March 31, 2015 and 2014 was $2.3 million and $4.3 million, respectively. The following table summarizes values for options granted during the respective years: Fiscal Years Ended March 31, 2015 2014 (in thousands) Weighted average grant date fair value $ 2,841 $ 672 Intrinsic value of options exercised $ 2 $ 48 Fair value of shares vesting during the year $ 287 $ 346 The following table summarizes activity for awards for the respective years: Shares Grant Date Fair Value Per Share Aggregate Intrinsic Value Balance at March 31, 2013 725 $ 5.53 $ 6,553 Awards granted 530 $ 6.91 $ — Awards vested/released (122 ) $ 6.74 $ — Awards cancelled/forfeited (494 ) $ 5.72 $ — Balance at March 31, 2014 639 $ 6.66 $ 4,255 Awards granted 234 $ 5.93 $ — Awards vested/released (362 ) $ 6.32 $ — Awards cancelled/forfeited (163 ) $ 6.43 $ — Balance at March 31, 2015 348 $ 6.18 $ 2,265 During fiscal 2015 and 2014, the fair value of rights granted under the employee stock purchase plan were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: Fiscal Year Ended Fiscal Year Ended March 31, 2015 March 31, 2014 Risk-free interest rate 0.06 % 0.09 % Dividend yield 0.00 % 0.00 % Expected volatility 28.4 % 58.3 % Expected term in years 0.50 0.50 Weighted average fair value at grant date $ 1.49 $ 2.81 For the fiscal years ended March 31, 2015 and 2014 the Company calculated the fair value of its employee stock options at the date of grant with the following weighted average assumptions: Fiscal Year Ended Fiscal Year Ended March 31, 2015 March 31, 2014 Risk-free interest rate 1.96 % 0.88 % Dividend yield 0 % 0 % Expected volatility 60.45 % 58.4 % Expected term in years 6.05 3.21 Weighted average fair value at grant date $ 3.73 $ 2.52 Equity Compensation Plan Information The table below demonstrates the number of options and awards issued and the number of options and awards available for issuance, respectively, under the Company’s current equity compensation plans as of March 31, 2015: Number of Weighted- Number of Securities Average Securities to be Exercise Remaining Issued upon Price Per Available Exercise Share of for Future of Outstanding Outstanding Issuance Options, Options Under Equity and Rights and Rights Compensation Plans (in thousands, except for per share amount) Equity compensation plans approved by stockholders 1996 Plan 1 $ 31.30 147 1999 Equity Incentive Plan 595 $ 6.14 232 Equity compensation plans not approved by stockholders 2001 Supplemental Plan -- $ -- 185 CEO Grant - Mathieu 187 $ 6.28 -- IASTA 664 $ 6.61 -- Total 1,447 $ 6.45 564 All vested shares granted under all Plans are exercisable; however, shares exercised but not vested under the 1996 Stock Plan are subject to repurchase. (1) Represents an option to purchase 187 thousand shares of our Common Stock granted to Mr. Mathieu outside of the 1996 and 1999 Stock Plan. The grant of this option did not require approval by our stockholders due to its qualification under the "inducement grant exception" provided by Nasdaq Listing Rule 5635(c)(4).

Note 14 - Basic and Diluted Net

Note 14 - Basic and Diluted Net Loss Per Share	12 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	14 . Basic and Diluted Net Loss Per Share Basic and diluted net loss per share has been computed using the weighted-average number of shares of common stock outstanding during the period. The Company excludes potentially dilutive securities from its diluted net loss per share computation when their effect would be antidilutive to net loss per share amounts. The following common stock equivalents were excluded from the net loss per share computation: At March 31, 2015 2014 (in thousands) Options 12 94 Unvested restricted stock units 31 572 Warrants 1,468 454 Total common stock equivalents excluded from diluted net loss per common share 1,511 1,120

Note 15 - Income Taxes

Note 15 - Income Taxes	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	1 5 . Income Taxes The provision for income taxes is based upon income (loss) before income taxes as follows (in thousands): March 31, 2015 2014 Domestic Pre-Tax Loss $ (13,683 ) $ (8,148 ) Foreign Pre-Tax Income/(loss) (63 ) (31 ) Total pre-tax loss $ (13,746 ) $ (8,179 ) March 31, 2015 2014 Federal tax at statutory rate $ (5,843 ) $ (2,735 ) Computed state tax (354 ) (148 ) Foreign rate differential 23 (11 ) Losses not benefited (3,729 ) 3,089 Change in tax reserve 2,808 152 Nondeductible expenses 815 (275 ) Research and development tax credits 3,330 (72 ) Income tax expense/(benefit) $ (2,950 ) $ - The components of the benefit for income taxes are as follows (in thousands): March 31, 2015 2014 Deferred Federal $ (2,901 ) $ - State (49 ) - (2,950 ) - Total provision for income taxes $ (2,950 ) $ - ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based on the weight of available evidence, which includes the Company's historical operation performance and the reported cumulative net losses in all prior years, the Company has provided a full valuation allowance against its net deferred tax assets. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets are as follows (in thousands): March 31, 2015 2014 Deferred Tax Assets: Net operating loss carryforward $ 16,206 $ 72,646 Intangible assets 8,486 11,535 Tax credit carryforwards 2,491 5,060 Reserves and accruals 531 155 Fixed assets - 14 Stock compensation 444 398 Deferred revenue - 523 28,158 90,331 Deferred Tax Liability Fixed assets (3 ) - Deferred revenue (27 ) - (30 ) - Gross Deferred Tax Asset 28,128 90,331 Valuation Allowance (28,128 ) (90,331 ) Net Deferred Tax Assets $ - $ - Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance that decreased by $62.2 million and increased by $3.2 million during 2015 and 2014 respectively. As of March 31, 2015 the Company had federal and state operating loss carryforwards of approximately $40.1 million and $38.2 million respectively. As of March 31, 2015, the Company Also had federal and state research and development tax credit carryforwards of approximately $51,000 and $5.0 million respectively. The federal net operating loss and credit carryforwards expire in various amounts between fiscal years ending March 31, 2019 through 2034, if not utilized. The state net operating loss carryforwards expire in various amounts between fiscal year ending March 31, 2016 through various dates, if not utilized. The state tax credit carryforwards have no expiration date. The Internal Revenue Code Section 382 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in the stock ownership of a company. In the event the Company has had a change in ownership, utilization of the carryforwards could be restricted. Based on its most recently performed study, the Company has concluded it had an ownership change on September 30, 2014 as defined by Section 382 of the Internal Revenue Code (IRC), which will limit the future realization of its net operating loss carryforwards since June 1999. Based on this recent study, the Company believes that the application of Section 382 will result in the forfeiture of $163 million net operating loss carryforward for federal income tax purposes and $48 million of net operating loss carryforward for California income tax purposes. In addition, based on this recent study, the Company has concluded that $3.5 million of the federal and none of California research tax credit carryforwards, respectively, would be subject to forfeiture due to Section 382 ownership changes under IRC Section 383 and/or possible credit amount reduction upon audit, but as noted above this is subject to review by the applicable taxing authority. Please note the research and development tax credit carryforwards above take into account this reduction. The Company is required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company policy is to record interest and penalties related to unrecognized tax benefits in income tax expense. At March 31, 2015, there was no liability for unrecognized tax benefits. A reconciliation of the beginning and ending unrecognized tax benefit amounts for fiscal year 2015 are as follows (in thousands): Balance at April 1, 2014 $ 2,102 Increases related to current year tax positions 13 Decreases related to Expiration of tax credits and derecognition (835 ) Balance at March 31, 2015 $ 1,280 The Company’s federal, state, and foreign tax returns are subject to examination by the tax authorities from inception due to net operating losses and tax carryforwards unutilized from such years.

Note 16 - 401(k) Benefit Plan

Note 16 - 401(k) Benefit Plan	12 Months Ended
	Mar. 31, 2015
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	16. 401(k) Benefit Plan The Company offers a tax-deferred savings plan, the Selectica 401(k) Plan (the 401(k) Plan), for the benefit of qualified employees. The 401(k) Plan is designed to provide employees with an accumulation of funds at retirement. Qualified employees may elect to make contributions to the 401(k) Plan on a monthly basis. Starting in fiscal 2012, the 401(k) Plan requires the Company to match the first 1% of all employee contributions. For the fiscal years ended March 31, 2015 and 2014, the Company contributed $0.3 million and $0.1 million, respectively, to the 401(k) Plan. Administrative expenses relating to the 401(k) Plan are insignificant.

Note 17 - Segment Information

Note 17 - Segment Information	12 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	17. Segment Information The Company operates as one business segment and therefore segment information is not presented.

Note 18 - Subsequent Events

Note 18 - Subsequent Events	13 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	18. Subsequent Events Private Placement Funding with Common Stock and Warrants On May 5, 2015, pursuant to a Subscription Agreement, dated as of February 6, 2015 (the “Subscription Agreement”), by and among the Company and certain members of the Company’s management and Board of Directors, the Company sold and issued to such investors (i) 65,955 shares of common stock of the Company, par value $0.0001 per share, at a purchase price of $4.70 per share, for a total purchase amount of approximately $310,000 and (ii) warrants to purchase common stock of the Company, initially exercisable for an aggregate of 32,975 shares of common stock. Conversion of Series F Stock At a special meeting of the stockholders of the Company on May 5, 2015, the stockholders approved the issuance of the shares of Series F Stock and 2015 Warrants issued in the 2015 Financing and the shares of common stock issued and sold to the management and director investors under the Subscription Agreement described above. Pursuant to the Company’s Certificate of Designation, Preferences and Rights of Series F Convertible Preferred Stock filed by the Company with the Delaware Secretary of State on February 4, 2015, upon such stockholder approval, each whole share of Series F Stock converted automatically into ten (10) shares of common stock at a conversion price of $4.70 per share of common stock, for a total of 1,188,291 conversion shares. 2015 Equity Incentive Plan The Company’s Board of Directors previously adopted the Selectica, Inc. 2015 Equity Incentive Plan (the “2015 Plan”). The Company’s stockholders approved the 2015 Plan at the special meeting of the stockholders held on May 5, 2015. Pursuant to the terms of the 2015 Plan, employees, directors and consultants of the Company, and any present or future parent or subsidiary corporation or other affiliated entity, may receive grants of stock options, restricted stock awards and/or restricted stock units of the Company and certain cash-based awards. Subject to permitted adjustments for certain corporate transactions, the 2015 Plan authorizes the issuance of up to 1,500,000 shares of Company common stock. The 2015 Plan will be administered by the Compensation Committee of the Company’s Board of Directors, which is comprised of independent members of the Board of Directors. The Compensation Committee has full and exclusive power to make all decisions and determinations regarding (i) the selection of participants and the granting of awards; (ii) the terms and conditions relating to each award; (iii) adopting rules, regulations and guidelines for carrying out the 2015 Plan’s purposes; and (iv) interpreting the provisions of the 2015 Plan. Amendments to Articles of Incorporation o r Bylaws On May 5, 2015, the Company filed with the Delaware Secretary of State a Certificate of Amendment to Second Amended and Restated Certificate of Incorporation, as amended that increased the number of authorized shares of the Company’s common stock from 15,000,000 shares to 35,000,000 shares. Resignation of CEO Entr y into an Agreement to Acquire b-pack announced it has entered into a definitive agreement to acquire b-pack SAS, a French société par actions simplifiée, a global leader in purchase-to-pay software and services, for approximately $12.5 million in cash and stock. Complementing Selectica’s offerings and go-to-market strategy, b-pack delivers solutions in eProcurement, Purchase to Pay, Asset Management, Budget Management, Invoice Management, and Expense Management. B-pack was founded in 2000, with its corporate headquarters in Atlanta, Georgia and operations in Aix-en-Provence near Marseille, France. B-pack’s executive team and staff members include approximately 50 people. The purchase price for b-pack is comprised of approximately 90% in Selectica common stock stock (calculated at a fixed price of $6.11 per share, resulting in 1,841,244 shares of common stock to be issued) and 10% in cash. In connection with the acquisition, Selectica will also grant options to purchase 700,000 shares of its common stock to the employees of b-pack. The transaction is currently expected to close during the second quarter of Selectica’s fiscal year 2016.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Mar. 31, 2015
Valuation and Qualifying Accounts [Abstract]
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	Schedule II: Valuation and Qualifying Accounts Accounts Receivable Allowance for Doubtful Accounts The following describes activity in the accounts receivable allowance for doubtful accounts for the years ended March 31, 2015 and 2014, respectively: Balance at Beginning of Period Increase (decrease) to Costs and Expenses Write Offs Reversal Benefit to Revenue Balance at End of Period Allowance for doubtful accounts (in $000’s) Fiscal year ended March 31, 2014 $ 111 $ 773 $ (637 ) $ — $ 247 Fiscal year ended March 31, 2015 $ 247 $ (42) $ — $ — $ 205

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Mar. 31, 2015
Accounting Policies, by Policy (Policies) [Line Items]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and include the accounts of the Company and our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (GAAP) requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the accounts receivable and sales allowances, fair values of financial instruments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of stock-based awards, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Reclassification, Policy [Policy Text Block]	Change in Presentation of Financial Statements In the prior year ended March 31, 2014, the Company changed the presentation of its financial statements to include third party consulting costs related to our Selectica Configuration Solutions in its cost of sales. Previously, these costs were included in research and development expenses. Reclassifications of $0.2 million from research and development expense to recurring cost of sales were made in fiscal 2014, to conform to the current year’s presentation. This reclassification of the prior year amounts does not change the previously reported operating loss or net loss.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments, and accounts receivable. The Company places its short-term investments in high-credit quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the balance sheet. The Company’s cash balances periodically exceed the FDIC insured amounts. Accounts receivable are derived from revenue earned from customers primarily located in the United States. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral. The Company maintains reserves for potential credit losses, and historically, such losses have not been significant.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of money market funds, certificates of deposits, and commercial paper. Fair values of cash equivalents approximated original cost due to the short period of time to maturity. The cost of securities sold is based on the specific identification method. The Company’s investment policy limits the amount of credit exposure to any one issuer of debt securities.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash The Company’s restricted cash consist of certificates of deposits for our credit card for our office in the UK.
Receivables, Policy [Policy Text Block]	Accounts Receivable, Net of Allowance for Doubtful Accounts The Company evaluates the collectability of its accounts receivable based on a combination of factors. When the Company believes a collectability issue exists with respect to a specific receivable, the Company records an allowance to reduce that receivable to the amount that it believes to be collectible. In making the evaluations, the Company will consider the collection history with the customer, the customer’s credit rating, communications with the customer as to reasons for the delay in payment, disputes or claims filed by the customer, warranty claims, non-responsiveness of customers to collection calls, and feedback from the responsible sales contact. In addition, the Company will also consider general economic conditions, the age of the receivable and the quality of the collection efforts.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment, Net Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on estimated useful lives. The estimated useful lives for computer software and equipment is three years, furniture and fixtures is five years, and leasehold improvements is the shorter of the lease term or estimated useful life.
Business Combinations Policy [Policy Text Block]	Business Combinations The Company accounts for acquisitions using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805 - Business Combinations. relationships and acquired patents and developed technology; and discount rates. Management’s estimates of fair value are based on assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.
Intangible Assets and Impairment of Long-Lived Assets, Policy [Policy Text Block]	Intangible Assets and Impairment of Long-Lived Assets Intangible assets consist of customer relationships, trade names, and acquired technology. Intangible assets are recorded at fair values at the date of the acquisition and, for those assets having finite useful lives, are amortized using the straight-line method over their estimated useful lives, which generally range from two to five years. The Company periodically reviews its intangible and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company then compares the carrying amounts of the assets with the future net undiscounted cash flows expected to be generated by such asset. Should an impairment exist, the impairment loss would be measured based on the excess carrying value of the asset over the asset’s fair value determined using discounted estimates of future cash flows. There was no impairment charge recorded during the year ended March 31, 2015.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill represents the excess of the purchase consideration over the net tangible and an identifiable intangible asset acquired in a business combination and is allocated to reporting units expected to benefit from the business combination. The Company tests goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the assets may be impaired. The Company has elected to first assess certain qualitative factors to determine whether it is more likely than not that the fair value of its single reporting operating unit is less than the carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. If the Company determines that it is more likely than not that the fair value is less than its carrying amount, then the two-step goodwill impairment test will be performed. The first step, identifying a potential impairment, compares the fair value of the reporting unit with its carrying amount. If the carrying amount exceeds its fair value, the second step will be performed; otherwise, no further step is required. The second step, measuring the impairment loss, compares the implied fair value of the goodwill with the carrying amount of the goodwill. Any excess of the goodwill carrying amount over the applied fair value is recognized as an impairment loss, and the carrying value of goodwill is written down to fair value. There was no impairment charge recorded during the year ended March 31, 2015.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company generates revenues by providing its software as a service solutions through subscription license arrangements and related professional services, as well as through perpetual and term licenses and related software maintenance and professional services. The Company presents revenue net of sales taxes and any similar assessments. Revenue recognition criteria the Company determines that any one of the four criteria is not met, the Company will defer recognition of revenue until all the criteria are met. Multiple-Deliverable Arrangements. Upon separating the multiple-deliverables into separate units of accounting, the arrangement consideration is allocated to the identified separate units based on a relative selling price hierarchy. The Company determines the relative selling price for a deliverable based on its vendor-specific objective evidence of selling price (“VSOE”), if available, or its best estimate of selling price (“BESP”), if VSOE is not available. The Company has determined that third-party evidence of selling price (“TPE”) is not a practical alternative due to differences in its service offerings compared to other parties and the availability of relevant third-party pricing information. The amount of revenue allocated to delivered items is limited by contingent revenue, if any. For professional services and subscription services, the Company has not established VSOE due to lack of pricing consistency, and other factors. Accordingly, the Company uses its BESP to determine the relative selling price. The Company determined BESP by considering its price list, as well as overall pricing objectives and market conditions. Significant pricing practices taken into consideration include the Company’s discounting practices, contract prices per user, the size and volume of the Company’s transactions, the customer demographic, and its market strategy. Recurring revenues. Non-recurring revenues. In certain arrangements with non-standard acceptance criteria, the Company defers the revenue until the acceptance criteria are satisfied. Reimbursements, including those related to travel and out-of-pocket expenses are included in non-recurring revenues, and an equivalent amount of reimbursable expenses is included in non-recurring cost of revenues.
Advertising Costs, Policy [Policy Text Block]	Advertising Expense The cost of advertising is expensed as incurred. Advertising expense for the years ended March 31, 2015 and 2014 was approximately $614,000 and $209,000 respectively.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency The Company’s UK subsidiary’s functional currency is the U.S. dollar. Non-monetary assets and liabilities are translated into U.S. dollar equivalents at the exchange rate in effect on the balance sheet date and revenues and expenses are translated into U.S. dollars using the average exchange rate over the period. The net gains and losses resulting from foreign exchange transactions are recorded in other income (expense), net in the condensed consolidated statement of operations.
Research, Development, and Computer Software, Policy [Policy Text Block]	Capitalized Software Development Costs Software development costs incurred prior to the establishment of technological feasibility are included in research and development expenses. The Company defines achievement of technological feasibility as the completion of a working model. Software development costs incurred subsequent to the establishment of technological feasibility through the period of general market availability of the products are capitalized, if material, after consideration of various factors, including net realizable value. Capitalized software costs are amortized once the product is available for general release, using the straight-line method over the estimated useful lives of the asset. Capitalized software developments costs are evaluated for recoverability based on estimated future gross revenues reduced by the associated costs. If gross revenues were to be significantly less than estimated, the net realizable value of the capitalized software would be considered impaired, which could result in the write-off of all or a portion of the unamortized balance of such capitalized software. During the years ended March 31, 2015 and 2014, the Company recorded impairment charges of $0.3 million and $0, respectively, related to our capitalized software development costs. These impairment charges are included in R&D expenses in the accompanying consolidated statements of operations (see Note 7).
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company recognizes stock-based compensation expense for only those awards ultimately expected to vest on a straight-line basis over the requisite service period of the award, net of an estimated forfeiture rate. The Company estimates the fair value of stock options using a Black-Scholes valuation model, which requires the input of highly subjective assumptions, including the option’s expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, its stock-based compensation expense could be materially different in the future.
Geographic Information [Policy Text Block]	Geographic Information: International revenues are attributable to countries based on the location of the customers. For the fiscal years ended March 31, 2015 and 2014, sales to international locations were derived primarily from Canada, India, New Zealand, Switzerland, Germany, Hong Kong, Ireland, Norway and the United Kingdom. Fiscal Years Ended March 31, 2015 2014 (in thousands, except percentages) International Revenues 13 % 10 % Domestic Revenues 87 % 90 % Total Revenues 100 % 100 % For the years ended March 31, 2015 and 2014, the Company held long-lived assets outside of the United States with a net book value of approximately $47,000 and $67,000, respectively. These assets were located in Odessa, Ukraine.
Stockholders' Equity, Policy [Policy Text Block]	Treasury Stock There were no stock repurchases during the fiscal year ended 2015 and 2014. The Company had 96,000 shares of treasury stock as of March 31, 2015 and March 31, 2014.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In April 2015, the Financial Accounting Standards Board (the “FASB”) issued ASU 2015-05, Intangibles − Goodwill and Other − Internal-use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement, In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In February 2015, the FASB issued ASU 2015-02, Consolidation (Subtopic 810): Amendments to the Consolidation Analysis In May 2014, the FASB issued ASC 2014-09, Revenue from Contracts with Customers (Subtopic 606),
Customer Concentration Risk [Member]
Accounting Policies, by Policy (Policies) [Line Items]
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Customer Concentrations A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years: Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer A 10 % 14 % Customers who accounted for at least 10% of gross accounts receivable were as follows: Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer B 15 % 29 %

Note 2 - Summary of Significa28

Note 2 - Summary of Significant Policies (Tables)	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer A 10 % 14 %
Schedule Of Accounts Receivable Y Major Customer [Table Text Block]	Fiscal Year Ended March 31, 2015 2014 (in thousands, except percentages) Customer B 15 % 29 %
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	Fiscal Years Ended March 31, 2015 2014 (in thousands, except percentages) International Revenues 13 % 10 % Domestic Revenues 87 % 90 % Total Revenues 100 % 100 %

Note 3 - Acquisition (Tables)

Note 3 - Acquisition (Tables)	12 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table Text Block]	(in thousands) Cash Paid $ 6,494 Total Stock value 6,610 Working Capital Adjustment $ (734 ) Total Purchase Price $ 12,370
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Summary (in thousands) Cash $ 1,491 Restricted cash 139 Accounts receivable 2,618 Prepaid and other Assets 314 Fixed assets, net 188 Customer relationships 4,210 Developed technology 3,170 Trade name 120 Goodwill 7,702 Other long term assets 340 Accounts payable and accrued expenses (562 ) Accrued and payroll benefits (688 ) Credit facility (655 ) Notes payable (277 ) Other current liabilities (718 ) Deferred revenue (2,033 ) Deferred tax asset - current 280 Deferred tax liability - non current (3,269 ) Total value of assets acquired and liabilities assumed $ 12,370
Business Acquisition, Pro Forma Information [Table Text Block]	2015 2014 (thousands, except per share data) Revenue $ 23,796 $ 26,271 Loss from operations $ (16,769 ) $ (9,139 ) Net Loss $ (13,952 ) $ (8,179 ) Basic and diluted net loss per share $ (1.92 ) $ (2.13 )

Note 4 - Goodwill and Purchas30

Note 4 - Goodwill and Purchased Intangible Assets (Tables)	12 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	(in thousands) Balance at beginning of fiscal year $ - Goodwill acquired 8,436 Working Capital Adjustment $ (734 ) Balance at end of fiscal year $ 7,702
Schedule of Finite-Lived Intangible Assets [Table Text Block]	March 31, 2015 Gross Accumulated Net Carrying Amortization Carrying Amount Value Acquired developed technology $ 3,170 $ 476 $ 2,694 Customer relationships 4,210 526 3,684 Trade name 120 45 75 $ 7,500 $ 1,047 $ 6,453
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year ended March 31: (in thousands) 2016 $ 1,396 2017 1,351 2018 1,336 2019 1,336 2020 919 Thereafter 115 Total $ 6,453

Note 5 - Private Placement Fu31

Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Tables)	12 Months Ended
	Mar. 31, 2015
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants [Abstract]
Schedule of Stock by Class [Table Text Block]	Carrying value of Series D Stock as of March 31, 2014 $ 3,653 Conversion of Series D stock into common stock (3,653 ) Carrying value of Series D Stock as of June 30, 2014 $ - Gross proceeds on July 2, 2014 $ 7,493 Fair value of warrants on July 2,2014 (809 ) Gross proceeds allocated to Series E Stock sold on July 2, 2014 6,684 Related transaction costs allocated (265 ) Net value allocated to Series E Stock sold prior to BCF 6,419 Calculated BCF value (1,571 ) Accretion of Series E Stock through August 27, 2014 2,645 Carrying value of Series D Stock as of August 27, 2014 7,493 Conversion of Series D stock into common stock (7,493 ) Carrying value of Series D Stock as of September 30, 2014 $ - Gross proceeds on February 5, 2015 $ 5,585 Fair value of warrants on January 5, 2015 (682 ) Gross proceeds allocated to Series F Stock sold on February 5, 2015 4,903 Related transaction costs allocated (490 ) Net value allocated to Series F Stock sold prior to BCF 4,413 Calculated BCF value (564 ) Accretion of Series E Stock through March 31, 2015 1,046 Carrying value of Series F Stock as of March 31, 2015 $ 4,895

Note 6 - Property and Equipme32

Note 6 - Property and Equipment, Net (Tables)	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	March 31, 2015 2014 (in thousands) Computers and software $ 562 $ 2,381 Furniture and equipment 260 774 Leasehold improvements 70 117 892 3,272 Less: accumulated depreciation (602 ) (2,960 ) Total property and equipment, net $ 290 $ 312

Note 8 - Balance Sheet Compon33

Note 8 - Balance Sheet Components (Tables)	12 Months Ended
	Mar. 31, 2015
Disclosure Text Block Supplement [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	2015 2014 (in thousands) Accrued payroll and related liabilities: Accrued vacation $ 561 $ 371 Accrued bonus 83 164 Accrued wages — — Accrued benefits 97 92 Accrued commissions 169 21 Total $ 910 $ 648 2015 2014 (in thousands) Other accrued liabilities: Accrued accounts payable $ 783 $ 150 VAT on sales 125 — Employee withhold tax for stock 227 19 Sales tax payable 662 76 Other accrued liabilities 80 100 Total $ 1,877 $ 345 2015 2014 (in thousands) Deferred revenue: $ $ Hosting 90 85 Consulting 656 138 Training 8 — Subscription 5,457 2,650 Maintenance 2,215 2,876 Other 6 — Total $ 8,432 $ 5,749

Note 13 - Stockholders' Equity

Note 13 - Stockholders' Equity (Tables)	12 Months Ended
	Mar. 31, 2015
Note 13 - Stockholders' Equity (Tables) [Line Items]
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]	Equity incentive plans: Awards outstanding 348,386 Options outstanding 1,099,323 Reserved for future grants 563,000 Total common stock reserved for future issuance 2,010,709
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Fiscal years Ended March 31, (in thousands) 2015 2014 Cost of revenues $ 459 $ 250 Research and development 213 167 Sales and marketing 836 345 General and administrative 1,030 385 Impact on net loss $ 2,538 $ 1,149
Schedule of Share-based Compensation, Activity [Table Text Block]	Options Outstanding Restricted Stock Units Outstanding Number of shares (in thousands) Weighted average exercise price Number of shares (in thousands) Weighted average fair value Outstanding at March 31, 2013 161 $ 7.76 724 $ 5.53 Granted 316 $ 6.28 530 $ 6.91 Granted outside of plan $ 6.85 Exercised (43 ) $ 5.32 (122 ) $ 5.72 Cancelled (48 ) $ 11.14 (493 ) Outstanding at March 31, 2014 386 $ 6.40 639 $ 6.88 Granted 61 $ 5.86 234 $ 5.93 Granted outside of plan 700 $ 6.61 - - Exercised (2 ) $ 3.70 (362 ) $ 6.32 Cancelled (46 ) $ 7.50 (163 ) $ 6.43 Outstanding at March 31, 2015 1,099 $ 6.46 348 $ 6.18 Vested and expected to vest 987 $ 6.45
Schedule of Shares Available for Grant [Table Text Block]	Shares Available for Grant Balance at March 31, 2013 673 Options: Shares added 187 Granted – approved plan (316 ) Cancelled 48 Restricted Stock Units: Granted (530 ) Cancelled 493 Balance at March 31, 2014 556 Options: Granted – approved plan (61 ) Cancelled 10 Restricted Stock Units: Granted (234 ) Cancelled 163 Released shares repurchased 129 Balance at March 31, 2015 563
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Options Outstanding Options Vested and Exercisable Range of Exercise Number Weighted- Number Weighted- Prices Per Share of Shares Average of Shares Average (in thousands) Remaining (in thousands) Exercise Price Contractual Per Share Life (Years) $3.70 - $5.72 103 6.49 90 $ 6.2 $5.83 - $6.28 61 9.46 13 $ 9.43 $6.28 - $6.83 187 8.68 58 $ 8.68 $6.30 - $34.00 748 9.12 69 $ 7.89 $3.70 - $34.00 1,099 $ 6.46 230 $ 6.18
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Fiscal Years Ended March 31, 2015 2014 (in thousands) Weighted average grant date fair value $ 2,841 $ 672 Intrinsic value of options exercised $ 2 $ 48 Fair value of shares vesting during the year $ 287 $ 346
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	Fiscal Year Ended Fiscal Year Ended March 31, 2015 March 31, 2014 Risk-free interest rate 0.06 % 0.09 % Dividend yield 0.00 % 0.00 % Expected volatility 28.4 % 58.3 % Expected term in years 0.50 0.50 Weighted average fair value at grant date $ 1.49 $ 2.81
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Fiscal Year Ended Fiscal Year Ended March 31, 2015 March 31, 2014 Risk-free interest rate 1.96 % 0.88 % Dividend yield 0 % 0 % Expected volatility 60.45 % 58.4 % Expected term in years 6.05 3.21 Weighted average fair value at grant date $ 3.73 $ 2.52
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Number of Weighted- Number of Securities Average Securities to be Exercise Remaining Issued upon Price Per Available Exercise Share of for Future of Outstanding Outstanding Issuance Options, Options Under Equity and Rights and Rights Compensation Plans (in thousands, except for per share amount) Equity compensation plans approved by stockholders 1996 Plan 1 $ 31.30 147 1999 Equity Incentive Plan 595 $ 6.14 232 Equity compensation plans not approved by stockholders 2001 Supplemental Plan -- $ -- 185 CEO Grant - Mathieu 187 $ 6.28 -- IASTA 664 $ 6.61 -- Total 1,447 $ 6.45 564
Stock Awards [Member]
Note 13 - Stockholders' Equity (Tables) [Line Items]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Shares Grant Date Fair Value Per Share Aggregate Intrinsic Value Balance at March 31, 2013 725 $ 5.53 $ 6,553 Awards granted 530 $ 6.91 $ — Awards vested/released (122 ) $ 6.74 $ — Awards cancelled/forfeited (494 ) $ 5.72 $ — Balance at March 31, 2014 639 $ 6.66 $ 4,255 Awards granted 234 $ 5.93 $ — Awards vested/released (362 ) $ 6.32 $ — Awards cancelled/forfeited (163 ) $ 6.43 $ — Balance at March 31, 2015 348 $ 6.18 $ 2,265

Note 14 - Basic and Diluted N35

Note 14 - Basic and Diluted Net Loss Per Share (Tables)	12 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	At March 31, 2015 2014 (in thousands) Options 12 94 Unvested restricted stock units 31 572 Warrants 1,468 454 Total common stock equivalents excluded from diluted net loss per common share 1,511 1,120

Note 15 - Income Taxes (Tables)

Note 15 - Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	March 31, 2015 2014 Domestic Pre-Tax Loss $ (13,683 ) $ (8,148 ) Foreign Pre-Tax Income/(loss) (63 ) (31 ) Total pre-tax loss $ (13,746 ) $ (8,179 )
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	March 31, 2015 2014 Federal tax at statutory rate $ (5,843 ) $ (2,735 ) Computed state tax (354 ) (148 ) Foreign rate differential 23 (11 ) Losses not benefited (3,729 ) 3,089 Change in tax reserve 2,808 152 Nondeductible expenses 815 (275 ) Research and development tax credits 3,330 (72 ) Income tax expense/(benefit) $ (2,950 ) $ -
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	March 31, 2015 2014 Deferred Federal $ (2,901 ) $ - State (49 ) - (2,950 ) - Total provision for income taxes $ (2,950 ) $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	March 31, 2015 2014 Deferred Tax Assets: Net operating loss carryforward $ 16,206 $ 72,646 Intangible assets 8,486 11,535 Tax credit carryforwards 2,491 5,060 Reserves and accruals 531 155 Fixed assets - 14 Stock compensation 444 398 Deferred revenue - 523 28,158 90,331 Deferred Tax Liability Fixed assets (3 ) - Deferred revenue (27 ) - (30 ) - Gross Deferred Tax Asset 28,128 90,331 Valuation Allowance (28,128 ) (90,331 ) Net Deferred Tax Assets $ - $ -
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	Balance at April 1, 2014 $ 2,102 Increases related to current year tax positions 13 Decreases related to Expiration of tax credits and derecognition (835 ) Balance at March 31, 2015 $ 1,280

Schedule II - Valuation and Q37

Schedule II - Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Mar. 31, 2015
Valuation and Qualifying Accounts [Abstract]
Summary of Valuation Allowance [Table Text Block]	Balance at Beginning of Period Increase (decrease) to Costs and Expenses Write Offs Reversal Benefit to Revenue Balance at End of Period Allowance for doubtful accounts (in $000’s) Fiscal year ended March 31, 2014 $ 111 $ 773 $ (637 ) $ — $ 247 Fiscal year ended March 31, 2015 $ 247 $ (42) $ — $ — $ 205

Note 2 - Summary of Significa38

Note 2 - Summary of Significant Policies (Details) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Minimum [Member]
Note 2 - Summary of Significant Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Maximum [Member]
Note 2 - Summary of Significant Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Computer Software and Equipment [Member]
Note 2 - Summary of Significant Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Note 2 - Summary of Significant Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Research and Development Expense [Member]
Note 2 - Summary of Significant Policies (Details) [Line Items]
Impairment of Capitalized Software	$ 300,000	$ 0
Reclassification From Research and Development Expenses To Cost Of Sales		200,000
Impairment of Intangible Assets (Excluding Goodwill)	0
Goodwill, Impairment Loss	0
Advertising Expense	614,000	209,000
Impairment of Capitalized Software	340,000
Long-Lived Assets	$ 47,000	$ 67,000
Treasury Stock, Shares, Acquired (in Shares)	0	0
Treasury Stock, Number of Shares Held (in Shares)	96,000	96,000

Note 2 - Summary of Significa39

Note 2 - Summary of Significant Policies (Details) - Major Customers by Revenues	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Customer Concentration Risk [Member] | Customer A [Member]
Revenue, Major Customer [Line Items]
Customer A	10.00%	14.00%

Note 2 - Summary of Significa40

Note 2 - Summary of Significant Policies (Details) - Major Customers by Accounts Receivable	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Credit Concentration Risk [Member] | Customer B [Member]
Note 2 - Summary of Significant Policies (Details) - Major Customers by Accounts Receivable [Line Items]
Customer B	15.00%	29.00%

Note 2 - Summary of Significa41

Note 2 - Summary of Significant Policies (Details) - Revenues from External Customers Attributed to Foreign Countries by Geographic Area	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues from External Customers Attributed to Foreign Countries by Geographic Area [Abstract]
International Revenues	13.00%	10.00%
Domestic Revenues	87.00%	90.00%
Total Revenues	100.00%	100.00%

Note 3 - Acquisition (Details)

Note 3 - Acquisition (Details) - USD ($) $ in Thousands	Jul. 02, 2014	Mar. 31, 2015
Iasta, Inc. [Member] | Line of Credit [Member]
Note 3 - Acquisition (Details) [Line Items]
Repayments of Assumed Debt	$ 700
Iasta, Inc. [Member] | Notes Payable to Banks [Member]
Note 3 - Acquisition (Details) [Line Items]
Repayments of Assumed Debt	$ 300
Iasta, Inc. [Member] | General and Administrative Expense [Member]
Note 3 - Acquisition (Details) [Line Items]
Business Combination, Acquisition Related Costs		$ 400
Iasta, Inc. [Member]
Note 3 - Acquisition (Details) [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)	1,000,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 6,610
Payments to Acquire Businesses, Gross	6,500
Escrow Deposit	$ 1,400
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Options Issued (in Shares)	700,000
Goodwill	$ 7,702
Goodwill		$ 7,702

Note 3 - Acquisition (Details)

Note 3 - Acquisition (Details) - Acquisition Purchase Price - USD ($) $ in Thousands	Jul. 02, 2014	Mar. 31, 2015
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Cash Paid		$ 4,451
Iasta, Inc. [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Cash Paid	$ 6,494
Total Stock value	6,610
Working Capital Adjustment	(734)
Total Purchase Price	$ 12,370

Note 3 - Acquisition (Details44

Note 3 - Acquisition (Details) - Fair Values of Assets Acquired and Liabilities Assumed in Acquisition - USD ($) $ in Thousands	Mar. 31, 2015	Jul. 02, 2014
Customer Relationships [Member] | Iasta, Inc. [Member]
Note 3 - Acquisition (Details) - Fair Values of Assets Acquired and Liabilities Assumed in Acquisition [Line Items]
Finite-lived intangibles		$ 4,210
Developed Technology Rights [Member] | Iasta, Inc. [Member]
Note 3 - Acquisition (Details) - Fair Values of Assets Acquired and Liabilities Assumed in Acquisition [Line Items]
Finite-lived intangibles		3,170
Trade Names [Member] | Iasta, Inc. [Member]
Note 3 - Acquisition (Details) - Fair Values of Assets Acquired and Liabilities Assumed in Acquisition [Line Items]
Finite-lived intangibles		120
Iasta, Inc. [Member]
Note 3 - Acquisition (Details) - Fair Values of Assets Acquired and Liabilities Assumed in Acquisition [Line Items]
Cash		1,491
Restricted cash		139
Accounts receivable		2,618
Prepaid and other Assets		314
Fixed assets, net		188
Goodwill		7,702
Other long term assets		340
Accounts payable and accrued expenses		(562)
Accrued and payroll benefits		(688)
Credit facility		(655)
Notes payable		(277)
Other current liabilities		(718)
Deferred revenue		(2,033)
Deferred tax asset - current		280
Deferred tax liability - non current		(3,269)
Total value of assets acquired and liabilities assumed		$ 12,370
Goodwill	$ 7,702

Note 3 - Acquisition (Details45

Note 3 - Acquisition (Details) - Pro Forma Financial Information - Iasta, Inc. [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 3 - Acquisition (Details) - Pro Forma Financial Information [Line Items]
Revenue	$ 23,796	$ 26,271
Loss from operations	(16,769)	(9,139)
Net Loss	$ (13,952)	$ (8,179)
Basic and diluted net loss per share (in Dollars per share)	$ (1.92)	$ (2.13)

Note 4 - Goodwill and Purchas46

Note 4 - Goodwill and Purchased Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 4 - Goodwill and Purchased Intangible Assets (Details) [Line Items]
Amortization of Intangible Assets (in Dollars)	$ 1	$ 0
Developed Technology Rights [Member]
Note 4 - Goodwill and Purchased Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	4 years 3 months
Customer Relationships [Member]
Note 4 - Goodwill and Purchased Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	5 years 3 months
Trade Names [Member]
Note 4 - Goodwill and Purchased Intangible Assets (Details) [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	1 year 3 months

Note 4 - Goodwill and Purchas47

Note 4 - Goodwill and Purchased Intangible Assets (Details) - Summary of Goodwill $ in Thousands	12 Months Ended
	Mar. 31, 2015USD ($)
Goodwill [Line Items]
Working Capital Adjustment	$ (734)
Balance as of	7,702
Iasta, Inc. [Member]
Goodwill [Line Items]
Goodwill acquired	$ 8,436

Note 4 - Goodwill and Purchas48

Note 4 - Goodwill and Purchased Intangible Assets (Details) - Summary of Intangible Assets Subject to Amortization $ in Thousands	Mar. 31, 2015USD ($)
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 7,500
Accumulated Amortization	1,047
Net Carrying Value	6,453
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,170
Accumulated Amortization	476
Net Carrying Value	2,694
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,210
Accumulated Amortization	526
Net Carrying Value	3,684
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	120
Accumulated Amortization	45
Net Carrying Value	$ 75

Note 4 - Goodwill and Purchas49

Note 4 - Goodwill and Purchased Intangible Assets (Details) - Future Amortization Expense for Finite-Lived Intangible Assets $ in Thousands	Mar. 31, 2015USD ($)
Future Amortization Expense for Finite-Lived Intangible Assets [Abstract]
2,016	$ 1,396
2,017	1,351
2,018	1,336
2,019	1,336
2,020	919
Thereafter	115
Total	$ 6,453

Note 5 - Private Placement Fu50

Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) - USD ($)	May. 05, 2015	Feb. 06, 2015	Aug. 27, 2014	Jul. 02, 2014	Apr. 10, 2014	Jan. 24, 2014	Mar. 31, 2015	Mar. 11, 2015	Feb. 05, 2015
January 2014 Financing [Member] | Common Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Share Price (in Dollars per share)						$ 6
January 2014 Financing [Member] | Lake Street Capital Markets [Member] | Series D Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues						980.4
January 2014 Financing [Member] | Lake Street Capital Markets [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues						11,029
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						10,416
January 2014 Financing [Member] | Series D Convertible Preferred Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues						68,047
Share Price (in Dollars per share)						$ 60
January 2014 Financing [Member] | Series D Preferred Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)						$ 0.0001
January 2014 Financing [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues						765,605
2014 Second Financing [Member] | Common Stock [Member] | Lake Street Capital Markets [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				37,467
Warrants and Rights Outstanding (in Dollars)				$ 800,000
2014 Second Financing [Member] | 2014 Second Investors [Member] | Series E Preferred Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues				124,890.5
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)				$ 0.0001
Share Price (in Dollars per share)				$ 60
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants (in Dollars)				$ 7,500,000
The July 2014 Warrants [Member] | Common Stock [Member] | 2014 Second Investors [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				312,223
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)				$ 7
Financing 2015 [Member] | Investors 2015 [Member] | Subsequent Event [Member] | Series F Preferred Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants (in Dollars)		$ 5,600,000
Financing 2015 [Member] | Investors 2015 [Member] | Series F Preferred Stock [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, New Issues		118,829.1
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)		$ 0.0001
Share Price (in Dollars per share)		$ 47
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		32,975
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$ 6
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants (in Dollars)		$ 5,600,000
Class of Warrant or Right Issued During Period Fair Value (in Dollars)		777,500
Common Stock [Member] | Series D Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities							690,274
Common Stock [Member] | Series E Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities							1,248,905
Additional Paid-in Capital [Member] | Series D Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Debt Instrument, Convertible, Beneficial Conversion Feature (in Dollars)							$ 600,000
Additional Paid-in Capital [Member] | Series E Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Debt Instrument, Convertible, Beneficial Conversion Feature (in Dollars)							$ 1,600,000
Investors 2014 [Member] | Private Placement [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)						$ 7
Investors 2014 [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						723,030
Subsequent Event [Member] | Series F Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion	10
Convertible Preferred Stock Per Share (in Dollars per share)	$ 4.70
Stock Issued During Period, Shares, Conversion of Convertible Securities	1,188,291
Series D Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion					10
Convertible Preferred Stock Per Share (in Dollars per share)					$ 6
Stock Issued During Period, Shares, Conversion of Convertible Securities					690,274
Series E Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion			10
Convertible Preferred Stock Per Share (in Dollars per share)			$ 6
Stock Issued During Period, Shares, Conversion of Convertible Securities			1,248,905
Preferred Stock, Redemption Amount (in Dollars)			$ 7,500,000
Series F Preferred Stock [Member]
Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]
Convertible Preferred Stock Conversion Rate Numerator (in Dollars)		$ 47
Share Price (in Dollars per share)							$ 6.50	$ 0.19
Warrants and Rights Outstanding (in Dollars)				$ 809,000					$ 682,000

Note 5 - Private Placement Fu51

Note 5 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) - Carrying Value of the Convertible Preferred Stock - USD ($) $ in Thousands	Feb. 05, 2015	Jul. 02, 2014	Sep. 30, 2014	Mar. 31, 2015	Aug. 27, 2014	Jun. 30, 2014	Mar. 31, 2015	Mar. 31, 2014
Class of Stock [Line Items]
Conversion of Series into common stock							$ (11,145)	$ (1,621)
Gross proceeds							12,319
Accretion of Series							3,691	3,513
Fair value of warrants on	$ (682)	$ (809)
Series D Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Carrying value of Series					$ 7,493			$ 3,653
Conversion of Series into common stock			$ (7,493)			$ (3,653)
Series E Preferred Stock and July 2014 Warrants [Member]
Class of Stock [Line Items]
Gross proceeds		7,493
Series E Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Gross proceeds		$ 6,684
Related transaction costs allocated					(265)
Net value allocated to common shares sold					6,419
Calculated BCF value					(1,571)
Accretion of Series				$ 1,046	$ 2,645
Series F Preferred Stock and 2015 Warrants [Member]
Class of Stock [Line Items]
Gross proceeds	5,585
Series F Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Carrying value of Series				4,895			$ 4,895
Gross proceeds	$ 4,903
Related transaction costs allocated				(490)
Net value allocated to common shares sold				4,413
Calculated BCF value				$ (564)

Note 6 - Property and Equipme52

Note 6 - Property and Equipment, Net (Details) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Abstract]
Depreciation	$ 262,000	$ 158,000

Note 6 - Property and Equipme53

Note 6 - Property and Equipment, Net (Details) - Property and Equipment - USD ($) $ in Thousands	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Gross	$ 892	$ 3,272
Less: accumulated depreciation	(602)	(2,960)
Total property and equipment, net	290	312
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Gross	562	2,381
Furniture and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Gross	260	774
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Gross	$ 70	$ 117

Note 7 - Capitalized Software (

Note 7 - Capitalized Software (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 7 - Capitalized Software (Details) [Line Items]
Impairment of Capitalized Software	$ 340
Capitalized Computer Software, Amortization	600	$ 10
Unamortized Balance of Capitalized Software	$ 2,300	$ 900
Computer Software, Intangible Asset [Member]
Note 7 - Capitalized Software (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years

Note 8 - Balance Sheet Compon55

Note 8 - Balance Sheet Components (Details) - Components of Accrued Payroll and Related Liabilities, Other Accrued Liabilities and Deferred Revenue - USD ($) $ in Thousands	Mar. 31, 2015	Mar. 31, 2014
Accrued payroll and related liabilities:
Accrued vacation	$ 561	$ 371
Accrued bonus	83	164
Accrued benefits	97	92
Accrued commissions	169	21
Total	910	648
Other accrued liabilities:
Accrued accounts payable	783	150
VAT on sales	125
Employee withhold tax for stock	227	19
Sales tax payable	662	76
Other accrued liabilities	80	100
Total	1,877	345
Deferred revenue:
Deferred revenue	8,432	5,749
Hosting [Member]
Deferred revenue:
Deferred revenue	90	85
Consulting [Member]
Deferred revenue:
Deferred revenue	656	138
Training [Member]
Deferred revenue:
Deferred revenue	8
Subscription Arrangement [Member]
Deferred revenue:
Deferred revenue	5,457	2,650
Maintenance [Member]
Deferred revenue:
Deferred revenue	2,215	$ 2,876
Other Deferred Revenue Arrangement [Member]
Deferred revenue:
Deferred revenue	$ 6

Note 9 - Operating Lease Comm56

Note 9 - Operating Lease Commitments (Details)	Jul. 02, 2014USD ($)ft²	May. 15, 2014USD ($)ft²	Mar. 31, 2015USD ($)	Mar. 31, 2014USD ($)
San Mateo Office Space [Member]
Note 9 - Operating Lease Commitments (Details) [Line Items]
Operating Leasing Area (in Square Feet) | ft²		10,516
Lessee Leasing Arrangements, Operating Leases, Term of Contract		25 months
Base Operating Lease		$ 2.85
Rent Escalating in Percent		3.00%
Carmel, Indiana Office Space [Member] | Iasta, Inc. [Member]
Note 9 - Operating Lease Commitments (Details) [Line Items]
Operating Leasing Area (in Square Feet) | ft²	9,948
Base Operating Lease	$ 1.80
Rent Escalating in Percent in Last Two Years of Lease	9.00%
Operating Leases, Rent Expense			$ 700,000	$ 200,000
Operating Leases, Future Minimum Payments Due, Next Twelve Months			600,000
Operating Leases, Future Minimum Payments, Due in Two Years			$ 300,000

Note 11 - Convertible Notes (De

Note 11 - Convertible Notes (Details) - USD ($)	Mar. 11, 2015	Mar. 31, 2015
Maximum [Member] | The Miller Group [Member] | Junior Secured Convertible Promissory Note [Member]
Note 11 - Convertible Notes (Details) [Line Items]
Debt Instrument Interest Rate in Event of Default	13.00%
The Miller Group [Member] | Junior Secured Convertible Promissory Note [Member]
Note 11 - Convertible Notes (Details) [Line Items]
Debt Instrument, Face Amount	$ 3,000,000
Debt Instrument, Maturity Date	Mar. 11, 2020
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Convertible, Conversion Price (in Dollars per share)	$ 5.70
Debt Instrument Paid In Kind Interest Rate	10.00%
Debt Extinguishment Threshold Not Exceeded	10.00%
Beneficial Conversion Feature Recorded as Debt Discount	$ 100,000
Debt Instrument, Convertible, Beneficial Conversion Feature	$ 100,000
Beneficial Conversion Feature Debt Discount Amortized to Interest Expense		$ 3,000
Largest Stockholder and MILFAM II LP Affiliates [Member] | Credit Faclity Guarantee [Member] | Other Noncurrent Liabilities [Member]
Note 11 - Convertible Notes (Details) [Line Items]
Guaranty Liabilities		200,000
Credit Faclity Guarantee [Member] | Other Noncurrent Liabilities [Member]
Note 11 - Convertible Notes (Details) [Line Items]
Guaranty Liabilities		$ 200,000
Share Price (in Dollars per share)	$ 0.19	$ 6.50

Note 12 - Credit Facility (Deta

Note 12 - Credit Facility (Details) - USD ($)	Mar. 11, 2014	Mar. 31, 2015	Mar. 31, 2014
Minimum [Member] | Receivable Financing Facility [Member]
Note 12 - Credit Facility (Details) [Line Items]
Line of Credit Facility, Interest Rate During Period		3.25%
Other Noncurrent Liabilities [Member] | Credit Faclity Guarantee [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guaranty Liabilities		$ 200,000
MILFAMIILP [Member] | Credit Faclity Guarantee [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 1,000,000
Largest Stockholders [Member] | Credit Faclity Guarantee [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted	1,000,000
Largest Stockholder and MILFAM II LP Affiliates [Member] | Credit Faclity Guarantee [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guarantor Obligations, Maximum Exposure, Undiscounted	$ 2,000,000
Guarantee Agreement Term	2 years
Guarantee Agreement PIK Commitment Fee Minimum Amount	$ 100,000
Largest Stockholder and MILFAM II LP Affiliates [Member] | Months 1-12 [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guarantee Agreement Monthly Fee Percentage	1.00%
Largest Stockholder and MILFAM II LP Affiliates [Member] | Months 13-24 [Member]
Note 12 - Credit Facility (Details) [Line Items]
Guarantee Agreement Monthly Fee Percentage	1.50%
Receivable Financing Facility [Member]
Note 12 - Credit Facility (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 5,000,000
Debt Instrument, Basis Spread on Variable Rate		0.25%
Working Capital Facility [Member]
Note 12 - Credit Facility (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 4,000,000
Debt Instrument, Basis Spread on Variable Rate		2.00%
Line Of Credit Facility Minimum Monthly Interest Charge		$ 2,000
Line of Credit Facility, Maximum Borrowing Capacity		$ 9,000,000
Line Of Credit Facility, Minimum Borrowing Base Requirement, Percentage Of Eligible Accounts Receivable		80.00%
Prepayment Penalty Rate		1.00%
Line Of Credit Facility Current Ratio Covenant		2
Long-term Line of Credit		$ 7,400,000	$ 6,900,000
Line of Credit Facility, Remaining Borrowing Capacity		$ 0	$ 0

Note 13 - Stockholders' Equit59

Note 13 - Stockholders' Equity (Details) - USD ($)	Dec. 03, 2012	Aug. 31, 2013	Mar. 31, 2015	Mar. 31, 2014	Mar. 11, 2015	Nov. 07, 2012
Maximum [Member] | Stock Plan 1996 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			10 years
Maximum [Member] | Plan 1999 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			10 years
Maximum [Member] | Supplemental Plan 2001 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			10 years
Vesting One Year After the Vesting Commencement Date [Member] | Stock Plan 1996 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			25.00%
Vesting One Year After the Vesting Commencement Date [Member] | Plan 1999 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			25.00%
Vesting One Year After the Vesting Commencement Date [Member] | Supplemental Plan 2001 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			25.00%
Based Upon Achievement of Committed Monthly Recurring Revenue Targets [Member] | Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	60.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Award Vesting Percentage, Amount Withheld from Vesting until Achievement of Profitability, Percent	50.00%
Vesting Based upon Operating Profit Targets [Member] | Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	40.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Employee Stock Purchase Plan (Member) | Originally Reserved for Issuance [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance						100,000
Employee Stock Purchase Plan (Member) | Per Purchase Date [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			5,000
Employee Stock Purchase Plan (Member) | Per Year [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			10,000
Employee Stock Purchase Plan (Member)
Note 13 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)			$ 80,000	$ 114,000
Percent of Fair Market Value			85.00%
Common Stock, Shares, Issued			48,833	37,533
Common Stock, Capital Shares Reserved for Future Issuance						553,000
Common Stock Purchased through Payroll Deductions, Maximum Percent of Employees' Cash Compensation			15.00%
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date			85.00%
Purchase Plan Eligibility, Minimum Number of Months Worked Per Year			5
Purchase Plan Eligibility, Minimum Number of Hours Worked Per Week			20
Percent Ownership Excluded from Plan			5.00%
Class of Warrant or Right, Maximum Amount Available to Purchase (in Dollars)			$ 25,000
Offering Period, Term			6 months
Purchase Plan, Term			20 years
Stock Plan 1996 [Member] | Nonstatutory Stock Options [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Percent of Fair Market Value			85.00%
Stock Plan 1996 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Percent of Fair Market Value			100.00%
Common Stock, Capital Shares Reserved for Future Issuance			815,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			36 months
Plan 1999 [Member] | First Year of Employment [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			66,000
Plan 1999 [Member] | Nonstatutory Stock Options [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Percent of Fair Market Value			85.00%
Plan 1999 [Member] | Incentive Stock Options [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Percent of Fair Market Value			100.00%
Plan 1999 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance			1,551,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			36 months
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			33,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	220,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Financial Officer [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	50,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Strategy Officer [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	50,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Operating Officer [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	50,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Chief Commercial Officer [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	50,000
Long Term Performance Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)			$ 100,000	$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	420,000
Supplemental Plan 2001 [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Percent of Fair Market Value			85.00%
Common Stock, Capital Shares Reserved for Future Issuance			250,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			36 months
Mr. Mathieu [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance			187,000
Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			234,000	530,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding (in Dollars)			$ 2,300,000	$ 4,300,000
CEO and COO [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense (in Dollars)		$ (500,000)
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)			$ 4,500,000
Common Stock, Shares, Issued			8,019,000	4,790,000
Common Stock, Capital Shares Reserved for Future Issuance			2,010,709
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			234,000	530,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term			7 years 189 days
Share Price (in Dollars per share)			$ 6.50		$ 0.19
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)			$ 198,000	$ 219,000

Note 13 - Stockholders' Equit60

Note 13 - Stockholders' Equity (Details) - Common Stock Reserved for Future Issuance - shares	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Equity incentive plans:
Awards outstanding	348,386
Options outstanding	1,099,323	386,000	161,000
Reserved for future grants	563,000	556,000	673,000
Total common stock reserved for future issuance	2,010,709

Note 13 - Stockholders' Equit61

Note 13 - Stockholders' Equity (Details) - Effect of Recording Stock-based Compensation Expense - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cost of Sales [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	$ 459	$ 250
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	213	167
Selling and Marketing Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	836	345
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	1,030	385
Impact on Net Loss (Member)
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated share-based compensation expense	$ 2,538	$ 1,149

Note 13 - Stockholders' Equit62

Note 13 - Stockholders' Equity (Details) - Activity Under the Equity Incentive Plans - $ / shares	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restricted Stock Units (RSUs) [Member] | Outside of Plan [Member]
Note 13 - Stockholders' Equity (Details) - Activity Under the Equity Incentive Plans [Line Items]
Restricted Stock Units, Granted, Weighted Average Fair Value		$ 6.85
Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) - Activity Under the Equity Incentive Plans [Line Items]
Restricted Stock Units, Number of Shares	348,000	639,000
Restricted Stock Units, Weighted Average Fair Value	$ 6.18	$ 6.88
Restricted Stock Units, Granted	234,000	530,000
Restricted Stock Units, Granted, Weighted Average Fair Value	$ 5.93	$ 6.91
Restricted Stock Units, Exercised	(362,000)	(122,000)
Restricted Stock Units, Exercised, Weighted Average Fair Value	$ 6.32	$ 5.72
Restricted Stock Units, Cancelled	(163,000)	(493,000)
Restricted Stock Units, Cancelled, Weighted Average Fair Value	$ 6.43
Outside of Plan [Member]
Note 13 - Stockholders' Equity (Details) - Activity Under the Equity Incentive Plans [Line Items]
Options, Granted	700,000
Options, Granted, Weighted Average Exercise Price	$ 6.61
Options, Number of Shares	1,099,323	386,000
Options, Weighted Average Exercise Price	$ 6.46	$ 6.40
Restricted Stock Units, Number of Shares	348,000	639,000
Restricted Stock Units, Weighted Average Fair Value	$ 6.18	$ 6.66
Vested and expected to vest	987,000
Vested and expected to vest	$ 6.45
Restricted Stock Units, Granted	234,000	530,000
Restricted Stock Units, Granted, Weighted Average Fair Value	$ 5.93	$ 6.91
Options, Granted	61,000	316,000
Options, Granted, Weighted Average Exercise Price	$ 5.86	$ 6.28
Options, Exercised	(2,000)	(43,000)
Options, Exercised, Weighted Average Exercise Price	$ 3.70	$ 5.32
Options, Cancelled	(46,000)	(48,000)
Options, Cancelled, Weighted Average Exercise Price	$ 7.50	$ 11.14
Restricted Stock Units, Cancelled	(163,000)	(494,000)
Restricted Stock Units, Cancelled, Weighted Average Fair Value	$ 6.43	$ 5.72

Note 13 - Stockholders' Equit63

Note 13 - Stockholders' Equity (Details) - Summary of Shares Available for Grant - shares	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Restricted Stock Units (RSUs) [Member]
Options:
Granted	(234,000)	(530,000)
Cancelled	163,000	493,000
Released shares repurchased	129,000
Approved Plan [Member]
Options:
Granted – approved plan	(61,000)	(316,000)
Balance	563,000	556,000
Shares added		187,000
Granted – approved plan	(61,000)	(316,000)
Granted	(234,000)	(530,000)
Cancelled	10,000	48,000

Note 13 - Stockholders' Equit64

Note 13 - Stockholders' Equity (Details) - Options Outstanding and Exercisable, by Exercise Range - Mar. 31, 2015 - $ / shares shares in Thousands	Total
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices Per Share - Minimum	$ 3.70
Options Outstanding, Number of Shares (in Shares)	103
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	6 years 178 days
Options Vested and Exercisable, Number of Shares (in Shares)	90
Options Vested and Exercisable, Weighted Average Exercise Price Per Share	$ 6.2
Range of Exercise Prices Per Share - Maximum	5.72
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices Per Share - Minimum	$ 5.83
Options Outstanding, Number of Shares (in Shares)	61
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	9 years 167 days
Options Vested and Exercisable, Number of Shares (in Shares)	13
Options Vested and Exercisable, Weighted Average Exercise Price Per Share	$ 9.43
Range of Exercise Prices Per Share - Maximum	6.28
Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices Per Share - Minimum	$ 6.28
Options Outstanding, Number of Shares (in Shares)	187
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	8 years 248 days
Options Vested and Exercisable, Number of Shares (in Shares)	58
Options Vested and Exercisable, Weighted Average Exercise Price Per Share	$ 8.68
Range of Exercise Prices Per Share - Maximum	6.83
Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices Per Share - Minimum	$ 6.30
Options Outstanding, Number of Shares (in Shares)	748
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	9 years 43 days
Options Vested and Exercisable, Number of Shares (in Shares)	69
Options Vested and Exercisable, Weighted Average Exercise Price Per Share	$ 7.89
Range of Exercise Prices Per Share - Maximum	34
Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices Per Share - Minimum	$ 3.70
Options Outstanding, Number of Shares (in Shares)	1,099
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	6 years 167 days
Options Vested and Exercisable, Number of Shares (in Shares)	230
Options Vested and Exercisable, Weighted Average Exercise Price Per Share	$ 6.18
Range of Exercise Prices Per Share - Maximum	$ 34

Note 13 - Stockholders' Equit65

Note 13 - Stockholders' Equity (Details) - Stock Option Activity - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Option Activity [Abstract]
Weighted average grant date fair value (in Dollars per share)	$ 2,841	$ 672
Intrinsic value of options exercised	$ 2	$ 48
Fair value of shares vesting during the year	$ 287	$ 346

Note 13 - Stockholders' Equit66

Note 13 - Stockholders' Equity (Details) - Activity for Awards for the Respective Years - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Activity for Awards for the Respective Years [Abstract]
Balance, shares	348	639	725
Balance, grant date fair value per share	$ 6.18	$ 6.66	$ 5.53
Balance, aggregate intrinsic value	$ 2,265	$ 4,255	$ 6,553
Awards granted, shares	234	530
Awards granted, grant date fair value per share	$ 5.93	$ 6.91
Awards vested/released, shares	(362)	(122)
Awards vested/released, grant date fair value per share	$ 6.32	$ 6.74
Awards cancelled/forfeited, shares	(163)	(494)
Awards cancelled/forfeited, grant date fair value per share	$ 6.43	$ 5.72

Note 13 - Stockholders' Equit67

Note 13 - Stockholders' Equity (Details) - Employee Stock Purchase Plan, Valuation Assumptions - $ / shares	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 13 - Stockholders' Equity (Details) - Employee Stock Purchase Plan, Valuation Assumptions [Line Items]
Weighted average fair value at grant date (in Dollars per share)	$ 2,841	$ 672
Employee Stock Purchase Plan (Member)
Note 13 - Stockholders' Equity (Details) - Employee Stock Purchase Plan, Valuation Assumptions [Line Items]
Risk-free interest rate	0.06%	0.09%
Dividend yield	0.00%	0.00%
Expected volatility	28.40%	58.30%
Expected term in years	6 months	6 months
Weighted average fair value at grant date (in Dollars per share)	$ 1.49	$ 2.81

Note 13 - Stockholders' Equit68

Note 13 - Stockholders' Equity (Details) - Stock Options, Valuation Assumptions - $ / shares	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Note 13 - Stockholders' Equity (Details) - Stock Options, Valuation Assumptions [Line Items]
Weighted average fair value at grant date (in Dollars per share)	$ 2,841	$ 672
Employee Stock Option [Member]
Note 13 - Stockholders' Equity (Details) - Stock Options, Valuation Assumptions [Line Items]
Risk-free interest rate	1.96%	0.88%
Dividend yield	0.00%	0.00%
Expected volatility	60.45%	58.40%
Expected term in years	6 years 18 days	3 years 76 days
Weighted average fair value at grant date (in Dollars per share)	$ 3.73	$ 2.52

Note 13 - Stockholders' Equit69

Note 13 - Stockholders' Equity (Details) - Equity Compensation Plan - $ / shares shares in Thousands	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2013
Equity compensation plans approved by stockholders
Number of Securities to be Issued upon Exercise of Outstanding Options and Rights	1,447
Weighted-Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$ 6.46	$ 6.40	$ 7.76
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	564
Stock Plan 1996 [Member]
Equity compensation plans approved by stockholders
Number of Securities to be Issued upon Exercise of Outstanding Options and Rights	1
Weighted-Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$ 31.30
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	147
Equity Incentive Plan [Member]
Equity compensation plans approved by stockholders
Number of Securities to be Issued upon Exercise of Outstanding Options and Rights	595
Weighted-Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$ 6.14
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	232
Supplemental Plan 2001 [Member]
Equity compensation plans approved by stockholders
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	185
Grant to CEO Blaine Mathieu [Member]
Equity compensation plans approved by stockholders
Number of Securities to be Issued upon Exercise of Outstanding Options and Rights	187
Weighted-Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$ 6.28
IASTA Plan [Member]
Equity compensation plans approved by stockholders
Number of Securities to be Issued upon Exercise of Outstanding Options and Rights	664
Weighted-Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$ 6.61

Note 14 - Basic and Diluted N70

Note 14 - Basic and Diluted Net Loss Per Share (Details) - Antidilutive Securities Excluded from the Computation of Earnings Per Share - shares shares in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities from computation of earnings per share	1,511	1,120
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities from computation of earnings per share	12	94
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities from computation of earnings per share	31	572
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities from computation of earnings per share	1,468	454

Note 15 - Income Taxes (Details

Note 15 - Income Taxes (Details) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
State and Local Jurisdiction [Member] | Research Tax Credit Carryforward [Member]
Note 15 - Income Taxes (Details) [Line Items]
Tax Credit Carryforwards Subject to Forfeiture	$ 0
State and Local Jurisdiction [Member]
Note 15 - Income Taxes (Details) [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(48,000,000)
Operating Loss Carryforwards	38,200,000
Deferred Tax Assets, Tax Credit Carryforwards, Research	5,000,000
Internal Revenue Service (IRS) [Member] | Research Tax Credit Carryforward [Member]
Note 15 - Income Taxes (Details) [Line Items]
Tax Credit Carryforwards Subject to Forfeiture	3,500,000
Internal Revenue Service (IRS) [Member]
Note 15 - Income Taxes (Details) [Line Items]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(163,000,000)
Operating Loss Carryforwards	40,100,000
Deferred Tax Assets, Tax Credit Carryforwards, Research	51,000
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(62,200,000)	$ 3,200,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$ 0

Note 15 - Income Taxes (Detai72

Note 15 - Income Taxes (Details) - Income (Loss) Before Income Taxes - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income (Loss) Before Income Taxes [Abstract]
Domestic Pre-Tax Loss	$ (13,683)	$ (8,148)
Foreign Pre-Tax Income/(loss)	(63)	(31)
Total pre-tax loss	$ (16,696)	$ (8,179)

Note 15 - Income Taxes (Detai73

Note 15 - Income Taxes (Details) - Income Tax Expense Reconciliation - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Tax Expense Reconciliation [Abstract]
Federal tax at statutory rate	$ (5,843)	$ (2,735)
Computed state tax	(354)	(148)
Foreign rate differential	23	(11)
Losses not benefited	(3,729)	3,089
Change in tax reserve	2,808	152
Nondeductible expenses	815	(275)
Research and development tax credits	3,330	(72)
Income tax expense/(benefit)	$ (2,950)	$ 0

Note 15 - Income Taxes (Detai74

Note 15 - Income Taxes (Details) - Components of Income Tax Expense (Benefit) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Deferred
Federal	$ (2,901)	$ 0
State	(49)	0
	(2,950)	0
Total provision for income taxes	$ (2,950)	$ 0

Note 15 - Income Taxes (Detai75

Note 15 - Income Taxes (Details) - Deferred Income Taxes - USD ($) $ in Thousands	Mar. 31, 2015	Mar. 31, 2014
Deferred Tax Assets:
Net operating loss carryforward	$ 16,206	$ 72,646
Intangible assets	8,486	11,535
Tax credit carryforwards	2,491	5,060
Reserves and accruals	531	155
Fixed assets		14
Stock compensation	444	398
Deferred revenue		523
	28,158	90,331
Deferred Tax Liability
Fixed assets	(3)
Deferred revenue	(27)
	(30)
Gross Deferred Tax Asset	28,128	90,331
Valuation Allowance	(28,128)	(90,331)
Net Deferred Tax Assets	$ 0	$ 0

Note 15 - Income Taxes (Detai76

Note 15 - Income Taxes (Details) - Unrecognized Tax Benefits $ in Thousands	12 Months Ended
	Mar. 31, 2015USD ($)
Unrecognized Tax Benefits [Abstract]
Balance	$ 2,102
Increases related to current year tax positions	13
Decreases related to Expiration of tax credits and derecognition	(835)
Balance	$ 1,280

Note 16 - 401(k) Benefit Plan (

Note 16 - 401(k) Benefit Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	1.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 0.3	$ 0.1

Note 17 - Segment Information (

Note 17 - Segment Information (Details)	12 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Number of Operating Segments	1

Note 18 - Subsequent Events (De

Note 18 - Subsequent Events (Details) - USD ($)	May. 05, 2015	Jun. 30, 2015	Mar. 31, 2015	Mar. 11, 2015	Mar. 31, 2014
Employee Severance [Member] | Scenario, Forecast [Member]
Note 18 - Subsequent Events (Details) [Line Items]
Restructuring Charges (in Dollars)		$ 200,000
Common Stock [Member] | Subsequent Event [Member] | Issuable Upon Stockholder's Approval [Member] | Purchase Agreement (Member)
Note 18 - Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, New Issues	65,955
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.0001
Share Price (in Dollars per share)	$ 4.70
Stock Issued During Period, Value, New Issues (in Dollars)	$ 310,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	32,975
Convertible Preferred Stock, Shares Issued upon Conversion	10
Convertible Preferred Stock, Initial Conversion Price (in Dollars per share)	$ 4.70
Conversion of Stock, Shares Converted	1,188,291
B-Pack [Member] | Scenario, Forecast [Member]
Note 18 - Subsequent Events (Details) [Line Items]
Payments to Acquire Businesses, Gross (in Dollars)		$ 12,500,000
Business Acquisition Percentage of Stock Purchase Price		90.00%
Business Acquisition, Share Price (in Dollars per share)		$ 6.11
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		1,841,244
Business Acquisition Percentage of Cash Paid		10.00%
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Options Issued		700,000
Subsequent Event [Member]
Note 18 - Subsequent Events (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,500,000
Common Stock, Shares Authorized	35,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)			$ 0.0001		$ 0.0001
Share Price (in Dollars per share)			$ 6.50	$ 0.19
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			1,447,000
Common Stock, Shares Authorized			15,000,000		15,000,000

Schedule II - Valuation and Q80

Schedule II - Valuation and Qualifying Accounts (Details) - Accounts Receivable Allowance for Doubtful Accounts - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Allowance for doubtful accounts (in $000’s):
Balance at Beginning of Period	$ 247	$ 111
Increase (decrease) to Costs and Expenses	(42)	773
Write Offs		(637)
Balance at End of Period	$ 205	$ 247

Uncategorized Items - sltc-2015

Label	Element	Value
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	$ 5.53
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	724